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Enhancing the catalytic efficiency of enzymes has been an aspiration for many 
years and protein engineering has been quite successful in this area. However, 
researchers are now turning their attention to the organisation of enzymes within 
cells to enhance whole pathway productivity. As such, bacterial microcompartments 
(BMCs) have attracted significant interest due to their ability to not only concentrate 
enzymes and metabolites but also prevent the release of toxic intermediates into the 
cell owing to their semi-permeable protein shell. The aim of the research described 
in this thesis was to develop a number of mechanisms to enhance the spatial 
organisation of proteins within E. coli and thereby increase metabolic productivity.  
 
The ability of BMC encapsulation peptides to target foreign proteins to a BMC was 
initially investigated. However, we found that the fusion of BMC encapsulation 
peptides to the enzymes of a 1,2-propanediol (1,2-PD) synthesis pathway resulted 
in the aggregation of the tagged enzymes rather than their localisation to a BMC. 
Nonetheless, the tagged enzymes were found to produce significantly more 1,2-PD 
than strains producing untagged enzymes, irrespective of the presence of BMCs, 
suggesting that it is the enzyme aggregate that results in enhanced substrate 
channelling. Furthermore, we showed that a highly conserved hydrophobic motif is 
conserved across a wide range of BMC targeting peptides and suggest that it is the 
amphipathic nature of these peptides that results in aggregation of tagged 
components. 
 
The ability of PduA, a component of the BMC shell, to form filamentous structures 
was investigated for its potential as a cytoplasmic scaffold. Targeting proteins to the 
cytoscaffold was explored through the use of de novo designed coiled-coil peptides. 
Localising the enzymes pyruvate decarboxylase and alcohol dehydrogenase on this 
scaffold by tagging them with the cognate coiled-coil peptide resulted in a significant 
enhancement in ethanol production in comparison to a strain lacking the scaffold. 
Additionally, we showed that it was possible to locate this intracellular scaffold to the 
inner membrane of the cell, further demonstrating the flexibility of this system. 
 
Finally, we utilised the same coiled-coil peptide technology to target fluorescent 
proteins to BMCs, overcoming the aggregation behaviour of the native targeting 
peptides. Through the re-design of a BMC shell protein we showed targeting occurs 
to both the external and luminal faces of these BMCs. Taken together, the evidence 
presented in this thesis provides a number of alternative strategies to not only 
enhance spatial organisation within a cell but also to increase productivity of 
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The greater complexity of eukaryotes is reflected in a higher level of sub-cellular 
organisation with specialised membrane bound organelles and a well-structured 
cytoskeleton in comparison to prokaryotic organisms. With this in mind bacteria 
were thought of as comparatively simple organisms, whilst the cellular 
compartmentalisation and organisation of eukaryotes permitted more complex 
multicellular life. The traditional view that prokaryotes represent a bag of enzymes 
that carry out metabolic processes by simple diffusion of metabolites between 
enzymes has persisted for many years. However, significant advances in 
prokaryotic cell biology, genome sequencing and improved imaging techniques 
have revealed that prokaryotes are significantly more organised than previously 
thought. 
 
1.1. Metabolic organisation in prokaryotes  
 
Several lines of evidence have led to the idea that metabolism, at least, is more 
organised in prokaryotes than was appreciated from early biochemical studies. 
Organisation of enzymes within metabolic pathways can lead to enhanced flux. This 
can be achieved by enzymes forming complexes, which has the effect of increasing 
the local concentration of substrates, reducing toxicity of pathway intermediates and 
minimizing the loss of intermediates to side reactions. These processes have given 
rise to terms such as substrate channelling – the transfer of a substrate from one 
active site to another without first diffusing into the bulk cytoplasmic environment 
(Miles et al., 1999; Spivey and Ovádi, 1999). Substrate channelling can occur by 
two mechanisms; the direct transfer of an intermediate from the catalytic site of one 
enzyme to that of another or by an increased local concentration of enzymes by 
specific localization (Spivey and Merz, 1989).  
 
1.2. Multienzyme complexes 
 
Complexes between multiple enzymes are seen frequently in nature. Such 
complexes allow for the direct channelling of pathway intermediates from one active 
site to another without loss to side reactions, such complexes can also protect 
against toxicity. For example, tryptophan synthase, catalysing the last step in 
tryptophan synthesis is a α2 β2 complex. The crystal structure of this complex 
reveals a hydrophobic tunnel that likely allows for the channelling of the toxic indole 
intermediate from the active site of the α subunit to the active site of the β subunit, 
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thereby preventing loss of this intermediate (Hyde et al., 1988; Hyde and Miles, 
1990).  Additionally, multienzyme complexes may be specifically localised within the 
cell resulting in a further enhancement to catalytic activity. Such complexes between 
multiple sequential enzymes and structural elements i.e. the cytoskeleton or 
membranes have been referred to as metabolons (Srere, 1985). 
1.3. Bacterial microcompartments 
 
Prokaryotic cells were long thought to have no internal cellular compartments as 
observed in eukaryotic cells. However, with the introduction of electron microscopy 
and subsequent improvements to this technology it has been revealed that 
prokaryotes do indeed contain intracellular compartments (Drews and Niklowitz, 
1956). These compartments, named bacterial microcompartments (BMCs), are 
proteinaceous organelles that consist of a semi-permeable outer shell encasing the 
enzymes associated with a specific metabolic process (Yeates et al., 2008; Kerfeld 
et al., 2010; Chowdhury et al., 2014). It has been shown that BMC shells are 
composed from several thousand individual polypeptides with an overall mass of 
between 100 and 600 MDa, therefore representing the largest protein complexes 
found in bacteria (Yeates et al., 2008; Cheng et al., 2008).  
 
The requirement for compartmentalisation of metabolic pathways has been 
extensively discussed since their first visualisation; to date two main theories have 
been put forward to explain their existence (Cheng et al., 2008; Kerfeld et al., 2010). 
 
One proposed advantage to compartmentalization is the increased local 
concentration of enzymes and substrates. The volume of a single E. coli cell is 
known to be approximately 1 µm3 resulting in the concentration of a single molecule 
in a cell being ~ 1 nM. The predicted volume of a 120 nm diameter BMC is 8.9 x 10 -
4 µm3 approximately 1000 times smaller than the volume of a cell (Sargent et al., 
2013). This decreased volume results in a high local concentration of molecules 
within the BMC lumen, with a single molecule within a BMC being approximately 1 
µM. The increased local concentration may allow for increased substrate 
channelling though encapsulated multi-enzyme pathways in comparison to soluble 
enzymes. Indeed a recent computational study has revealed that the main 
advantage of encapsulation of a pathway is the increased luminal intermediate 
concentrations in comparison to cytosolic concentrations therefore leading to 
enhance metabolic flux (Jakobson et al., 2017b).  
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The second proposed hypothesis is that the shell of the BMC provides a barrier that 
prevents the release of damaging toxic intermediates and the loss of intermediates 
to side reactions. Genetic analysis reveals that a common feature of BMCs is that 
they encapsulate a pathway involving the production and consumption of a toxic or 
volatile intermediate further supporting this hypothesis (Penrod and Roth, 2006; Dou 
et al., 2008; Sampson and Bobik, 2008; Yeates et al., 2010).  
 
1.3.1. BMCs in nature 
 
A recent genomics study has revealed that approximately 17% of bacteria contain a 
BMC locus (Axen et al., 2014). The widespread distribution of bacterial 
microcompartments across 23 phyla suggests that they are transferred by lateral 
transfer of BMC operons, thus providing an immediate advantage to the host rather 
than the transfer of individual genes (Lawrence and Roth, 1996; Bobik et al., 1999; 
Hess et al., 2001; Axen et al., 2014).  
 
It is understood that two main classes of BMCs exist; anabolic carboxysomes that 
fix carbon and catabolic metabolosomes that contain a signature aldehyde-
generating enzyme (Axen et al., 2014). 
 
1.3.2. Anabolic BMCs, the α and β carboxysome 
 
Carboxysomes were the first intracellular BMC to be visualised and remain the best 
characterised of the BMC systems in terms of both structural information and 
knowledge of the encapsulated pathway (Drews and Niklowitz, 1956). These 
macromolecular structures contain the enzymes required to fix CO2, ribulose-1,5-
bisphosphate carboxylase oxygenase (RuBisCO) and carbonic anhydrase (CA) 
(Shively et al., 1973; Cannon and Shively, 1983; Fukuzawa et al., 1992). The 
enzymes are encased within the semi-permeable protein shell of the BMC (Kerfeld 
et al., 2005; Iancu et al., 2007). It has been estimated that carboxysomes account 
for approximately 25% of global carbon fixation (Rae et al., 2013). Genetic analysis 
has revealed that carboxysome genes are present in all cyanobacteria and some 
chemoautotrophic bacteria (Yeates et al., 2010).  
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The evolution of carboxysomes as part of the CO2 concentrating mechanism (CCM) 
is thought to have been driven by changes in atmospheric conditions. Approximately 
350 million years ago there was a large drop in atmospheric CO2 levels and an 
increase in O2 levels (Bergman et al., 2004; Berner, 2006). This change in 
atmospheric conditions is proposed to be the driving force for the development of 
the CO2 concentrating mechanism (CCM) to overcome the inefficient activity of 
RuBisCO (Badger and Price, 2003). 
 
Carboxysomes can be split into two classes; α, encoded by the cso operon and β 
encoded by the ccm operon. The two classes are distinguished by their genetic 
makeup, shell composition and the enzymes that they encapsulate (Rae et al., 
2013). Phylogenetically, α-carboxysomes are found in cyanobacteria (termed α-
cyanobacteria) and some chemoautotrophic bacteria whereas β-carboxysomes are 
found solely in cyanobacteria (termed β-cyanobacteria) (Rae et al., 2013; Axen et 
al., 2014). The genetic information encoding α-carboxysomes is organised into an 
operon whereas β-carboxysome genes are dispersed throughout the genome 
(Cannon et al., 2001). Both α- and β-carboxysomes form polyhedral structures in-
vivo, however, β carboxysomes are known to be larger and more varied in size (175 
– 500 nm in diameter) compared to α-carboxysomes, which have an average size of 
120 nm (Figure 1) (Shively et al., 1977; van Eykelenburg, 1980; Long et al., 2007; 





Figure 1. TEM analysis of strains producing carboxysomes. (A) β-Carboxysomes 
present in Synechococcus elongatus PCC 7942. (B) α-Carboxysomes present in 
Cyanobium PCC 7001. Arrows indicate carboxysome structures (Rae et al., 2013). 
 
The process of carbon fixation begins with the uptake of dissolved inorganic carbon 
in the form of bicarbonate and CO2 into the cytoplasm as bicarbonate by a number 
of membrane transporters (Price, 2011). It is thought that bicarbonate diffuses 
throughout the cytoplasm and into the carboxysome through pores in the BMC shell 
(Kerfeld et al., 2005). The positive charge of central pore of hexameric shell proteins 
has been suggested to enhance transport of bicarbonate across the shell of the 
BMC whereas uncharged O2 and CO2 do not confer this advantage (Kerfeld et al., 
2005; Tsai et al., 2007; Yeates et al., 2008). 
 
Carbonic anhydrase then dehydrates bicarbonate to CO2 within the lumen of the 
BMC, which is converted with ribulose 1,5-bisphosphate (RuBP) by RuBisCO into 
two molecules of 3-phosphoglyceric acid (3-PGA), which diffuses out of the 
carboxysome and enters central metabolism. The production of CO2 within the 
lumen of the BMC is thought to overcome the slow catalytic activity of RuBisCO (kcat 
11.6 sec-1) by increasing the local concentration of its substrate (Morell et al., 1994; 
Tcherkez et al., 2006). This high local concentration of CO2 is also thought to inhibit 
the reaction of RuBisCO with O2 which leads to inefficient photorespiration (Moroney 
et al., 2013). The shell of the carboxysome is known to prevent the leakage of CO2 
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into the cytoplasm, and therefore its release into the environment due to the poor 
retention of CO2 by lipid bilayers (Price and Badger, 1989; Dou et al., 2008). It has 
also been shown that RuBisCO is less inhibited by O2 within a carboxysome shell in 
comparison to a cytoplasmic RuBisCO suggesting that the carboxysome provides a 
diffusion barrier to O2, although how a shell differentiates between CO2 and O2 is 
unclear (Marcus et al., 1992). 
 
1.3.3. Catabolic BMCs 
 
Catabolic BMCs, also termed metabolosomes, are involved in a variety of metabolic 
processes (Brinsmade et al., 2005; Axen et al., 2014). The BMC associated with 
1,2-propanediol (1,2-PD) utilisation is, to date, the best characterized of the 
catabolic BMCs with both wild type and recombinant systems developed to 
understand the functional characteristics of these compartments (Bobik et al., 1997; 
Bobik et al., 1999; Havemann and Bobik, 2003; Parsons et al., 2008; Parsons et al., 
2010). 
 
1.3.3.1. 1,2-Propanediol utilization 
 
In 1994 sequence analysis of S. enterica revealed a protein with a high degree of 
sequence similarity to the carboxysome shell protein CcmK (Chen et al., 1994). This 
gene, pduA, is located in an operon involved in 1,2-PD degradation and therefore it 
was concluded that S. enterica may produce a similar structure to the carboxysome 
for the degradation of 1,2-PD (Chen et al., 1994). Subsequently, during growth in 
the presence of 1,2-PD, microcompartments were visualised that were similar in 
size and appearance to the carboxysome (Figure 2) (Bobik et al., 1999). These 100 
– 200 nm diameter BMCs contain the enzymes required to convert 1,2-PD to 1-
propanol or propionate via the toxic intermediate propionaldehyde (Bobik et al., 
1999). It has been shown that this metabolosome has an approximate mass of 600 





Figure 2. Electron micrograph of S. enterica grown aerobically on minimal, 1,2-
propanediol, vitamin B12 medium. Arrows indicate BMCs. Scale bar shows 100 nm. 
(Bobik et al., 1999). 
 
Metabolism of 1,2-PD is thought to be of significant importance in anaerobic 
environments such as the intestines of higher animals where it is produced as a 
fermentation product of two plant sugars, fucose and rhamnose (Badia et al., 1985; 
Obradors et al., 1988). Genetic analysis has revealed that the genes required for 
1,2-PD degradation are found in a number of enteric and soil dwelling bacteria 
including Klebsiella, Lactobacillus, Lactococcus, Listeria, Salmonella, Shigella, 
Yersinia and at least one species of Escherichia coli (Cheng et al., 2008). It has also 
been suggested that 1,2-PD utilising BMCs play a role in the growth and 
transmission of enteric pathogens (Chowdhury et al., 2014). 
 
1.3.3.2. The pdu operon  
 
The genes for the production of BMCs for the utilisation of 1,2-PD are housed on a 
21-gene operon (Bobik et al., 1999). pocR and pduF are located adjacent to the 
main pdu operon and encode a transcriptional regulatory protein and a 1,2-PD 
diffusion facilitator, respectively (Chen et al., 1994). Seven of the 21 main operon 
genes encode 1,2-PD degrading enzymes (PduCDELPQW), nine encode BMC shell 
 15 
proteins (PduABB’JKMNTU), five are associated with vitamin B12 recycling and 
reactivation of the PduCDE complex (PduGHOSX) and one (PduV) is thought to 
play a role in the spatial segregation of BMCs (Cheng et al., 2008; Parsons et al., 
2010). 
 
1.3.3.3. The pathway of 1,2-propanediol utilisation 
 
The conversion of 1,2-PD to propionaldehyde is catalysed by the coenzyme B12 
dependent diol dehydratase PduCDE complex (Bobik et al., 1997). Propionaldehyde 
is then converted to either 1-propanol by 1-propanol dehydrogenase (PduQ) or to 
propionyl-CoA by propionaldehyde dehydrogenase (PduP) (Figure 3) (Leal et al., 
2003; Cheng et al., 2012). Propionyl-CoA is converted by PduL, a 
phosphotranscyclase to propionyl-phosphate, which is subsequently converted to 
propionate by the propionate kinase (PduW) (Palacios et al., 2003; Liu et al., 2007). 
Under aerobic conditions some propionyl-CoA is fed into the methyl citrate pathway, 
a pathway that does not function under anaerobic conditions (Jeter, 1990; Horswill 
and Escalante-Semerena, 1997; Horswill and Escalante-Semerena, 1999).   
 
1.3.3.4. Reactivation of the PduCDE diol dehydratase  
 
During the first step of 1,2-PD degradation requiring Ado-B12 a side reaction can 
occur leading to the exchange of the upper Ado ligand to an OH which remains 
bound to the diol dehydratase complex (Honda et al., 1980; Ushio et al., 1982). The 
OH-B12 is removed from the complex by the PduGH reactivase and subsequently 
converted back to the Ado-B12 form by PduS and PduO (Mori et al., 1997; Johnson 




Figure 3. The pathway of 1,2-propanediol degradation. 
 
1.3.4. Structural characteristics of BMCs 
 
Despite the diverse functionality offered by different BMCs the proteins that form the 
facets of these structures are homologous. BMC shell proteins can be divided into 3 
categories; hexamers (BMC-H), trimers (BMC-T) and pentamers (BMC-P). Both 
hexamers and trimers form the major component of the BMC shell (Havemann and 
Bobik, 2003). These proteins contain either a single (BMC-H) or double (BMC-T) 
BMC domain (pfam00936). This domain, approximately 90 amino acids in length 
forms a characteristic structure consisting of four antiparallel β-sheets surrounded 































known to form stacked dimers containing a central cavity (Klein et al., 2009). A 
number of variations on this canonical structure are observed in nature; domains 
can be linked to form a tandem domain or permuted to create a new N and C 
terminus while retaining the overall BMC domain architecture (Crowley et al., 2008). 
Numerous structural studies reveal a central pore within the hexameric disk, thought 
to allow for the transport of metabolites into and out of the BMC (Havemann et al., 
2002; Kerfeld et al., 2005).  
 
Pentameric proteins, containing a structural domain (pfam03319) are proposed to 
cap the vertices of the compartment. Although it must be noted that deletion of two 
pentameric CsoS4 proteins in H. neapolitanus resulted in the formation of BMCs 
that appear to be structurally similar to wild type however; some elongated 
structures were also formed (Cai et al., 2009). Similarly, recombinant expression of 
just H. ochraceum hexameric and trimeric shell proteins resulted in the appearance 
of regularly shaped BMCs (Lassila et al., 2014). 
 
Structural and sequence analysis has revealed a strong conservation of both the 
hexameric and pentameric BMC domains between BMC subtypes (Figure 4) (Frank 
et al., 2013).  
 
 
Figure 4. Relationships between shell proteins from anabolic and catabolic BMCs. 
Adapted from (Frank et al., 2013). 
 
Despite this wealth of knowledge regarding the individual components of the BMC 
shell the organisation of each of the shell proteins within the shell was not clear. 
Recently a previously investigated BMC of unknown function has been crystallized 
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revealing the organisation of shell proteins within the BMC shell (Lassila et al., 2014; 
Sutter et al., 2017). The hexamer, three trimers and one of the three pentamers 
were recombinantly expressed, purified and studied by cryo-electron microscopy 
and crystallography (Sutter et al., 2017). The shell proteins assemble into a 40 nm 
diameter icosahedron composed of 60 hexamers, 20 trimers and 12 pentamers 
located at the vertices (Figure 5).  
 
 
Figure 5. Crystal structure of a BMC shell of unknown function from Haliangium 
ochraceum. Hexamers – blue, trimers – green and pentamers - yellow  (Sutter et al., 
2017). 
 
The structure reveals four well-defined protein-protein interfaces, two hexamer-
hexamer interactions, the hexamer-trimer interaction and the hexamer-pentamer 
interaction. Hexamers are arranged in both a coplanar orientation, in the case of 
those connecting pentamers or bent at 30°, when surrounding a pentamer. The 
hexamer-pentamer interaction is similarly bent 30°, the hexamer-trimer interaction is 
bent at 25°. Due to the high degree of sequence conservation between BMC types 
these interactions are likely to be conserved. 
 
Both hexamers and trimers have a distinct concave and convex surface, the 
structure reveals that the concave side faces out, for stacked trimers the lower 
trimer that is embedded within the shell is orientated in the same direction. Similarly 
the pentameric vertex proteins are orientated with the convex side facing the lumen 
(Sutter et al., 2017). 
 
Given the high degree of conservation among shell proteins of all BMC types this 
organisation is likely to be conserved (Kerfeld and Erbilgin, 2015). 
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1.3.5. The shell of the 1,2-Propanediol utilizing BMC 
 
The shell of the BMC associated with 1,2-PD utilization is composed of 9 shell 
proteins (Bobik et al., 1999; Sinha et al., 2012). The functionality of these shell 
proteins has been determined by mutagenesis, crystallography and sequence 
alignments. 
 
Numerous studies have analyzed the size of BMCs associated with 1,2-PD 
utilisation; an initial study showed that BMCs in S. enterica were 100 – 200 nm in 
diameter (Bobik et al., 1999). A more detailed recent study has found that purified 
metabolosomes from C. freundii are approximately 125 nm in diameter (Mayer et 
al., 2016). 
 
The absence of a BMC shell in the presence of 1,2-PD results in arrested growth, 
supporting the hypothesis that this metabolosome sequesters the toxic 
propionaldehyde intermediate (Havemann et al., 2002; Sampson and Bobik, 2008; 




PduA is a 93 amino acid protein containing a single BMC domain that forms a 
hexameric disk with a central 9 Å pore proposed to allow for the transport of the 
substrate, 1,2-PD into the compartment (Figure 6) (Crowley et al., 2010; Pang et al., 
2014). Sequence analysis shows that it is related to major carboxysome shell 
proteins. It was initially suggested that a pduA deletion mutant was not able to form 
BMCs, however this was further shown to be a double deletion including pduB 
(Havemann et al., 2002; Cheng et al., 2011). Analysis of a correct pduA deletion 
mutant showed that it is not required for BMC formation although the BMCs formed 
are enlarged compared to wild type (Cheng et al., 2011). 
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Figure 6. Crystal structure of the S. enterica PduA hexamer (Crowley et al., 2010). 
 
The central pore of the hexamer is thought to allow for the transport of 1,2-PD into 
the lumen of the BMC (Pang et al., 2014). Transport is proposed to be facilitated by 
the hydrogen bond donors and acceptors lining the pore whereas propionaldehyde, 
the toxic intermediate of the 1,2-PD utilization pathway is more hydrophobic than 
1,2-PD and only posses a single hydrogen bond donor, potentially limiting its 
escape from the BMC (Crowley et al., 2010). 
 
1.3.5.2. PduB and PduB’ 
 
PduB is a tandem BMC domain protein and has been suggested to form a gated 
pore (Klein et al., 2009; Tanaka et al., 2010; Pang et al., 2012; Sutter et al., 2017). 
Two forms of PduB are produced; PduB and PduB’ the latter resulting from a 
second translational start site and therefore lacking the 37 N-terminal residues of 
the full length PduB protein (Havemann and Bobik, 2003; Parsons et al., 2010). The 
large central pore of PduB/PduB’ is thought to permit for the transport of large 
cofactors into the BMC (Tanaka et al., 2010). The presence of glycerol in the 
smaller pores, a molecule that is highly similar to 1,2-PD suggests that these pores 
may facilitate transport of this substrate (Sagermann et al., 2009; Tanaka et al., 
2010; Pang et al., 2012). A pduBB’ deletion mutant inhibits the formation of BMCs 
and results in the formation of inclusion bodies at the poles of 20% of the observed 
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cells (Cheng et al., 2011). Additionally, aldehyde toxicity is observed during growth 
on 1,2-PD in pduB mutant strains suggesting that BMCs are not functional (Cheng 




PduJ shares a high level of sequence similarity to PduA (86%) with pore lining 
residues also conserved (Crowley et al., 2010). It is therefore assumed, like PduA, 
to form a hexameric disk, and indeed the crystal structure reveals that the structures 
of PduA and PduJ are almost identical (Chowdhury et al., 2016). However unlike 
PduA, deletion of pduJ inhibits the formation of BMCs although elongated structures 




PduK is a single BMC domain protein. Unlike PduA and PduJ it contains a ~70 
amino acid C-terminal extension (Chowdhury et al., 2014). This C-terminal region 
contains a Fe-S binding motif (CNLCLDPKCPRQKGEPRTLC). The purified protein 
is shown to bind iron further supporting the hypothesis of an Fe-S center, although 
no firm experimental evidence for an Fe-S center has been presented (Crowley et 
al., 2010). It has been shown that a pduK deletion mutant results in protein 





The role of PduM, a 163 amino acid protein, is uncertain. It does not contain a BMC 
domain and lacks sequence similarity to any protein of known function (Sinha et al., 
2012). The requirement for PduM in shell formation is unclear; deletion mutants 
resulted in the appearance of abnormally shaped BMCs and shaped cytoplasmic 
aggregates suggesting its essential role in the formation of wild type BMCs (Sinha et 
al., 2012). It must however be noted that empty BMCs can be formed in the 
absence of PduM (Parsons et al., 2010). Therefore further structural and 






PduN is similar in amino acid sequence to other pentameric BMC shell proteins 
such as EutN (Eut BMC), CsoS4 (α-carboxysome) and CcmL (β-carboxysome) 
(Frank et al., 2013). PduN is predicted to form the vertices of the BMC and therefore 
is expected to be of low abundance in comparison to other BMC shell proteins 
(Parsons et al., 2010). Indeed a recent study has shown that it makes up 
approximately 2% of the metabolosome shell (Mayer et al., 2016) Deletion of pduN 
results in impaired growth on 1,2-propanediol and the appearance of abnormal BMC 




PduU, a single BMC domain protein with a pore capped by a β-barrel is circularly 
permuted (Crowley et al., 2008). It contains a unique six-stranded β-barrel that 
appears to block the central pore the role of which is currently unclear, however it 
has been proposed to be involved in binding to specific enzymes rather than for 
metabolite transport (Crowley et al., 2008). Structurally characterized transport 
proteins containing a β-barrel are composed of twelve or more strands resulting in a 
much larger diameter pore. Another hypothesis is that the β-barrel may undergo 
conformational change under certain conditions to open up the channel to transport 
molecules into and out of the BMC (Crowley et al., 2008). 
 
Deletion of pduU does not impair BMC formation and no significant difference in the 





PduT like PduB contains two BMC domains and forms a pseudohexameric 
homotrimer (Crowley et al., 2010). The central pore of the PduT trimer contains a 
[4Fe-4S] centre, with three cysteine residues (C38) providing ligands although it 
must be noted that the fourth ligand has to date not been identified (Crowley et al., 
2010). The [4Fe-4S] centre is accessible from both sides of the hexamer suggesting 
the protein may play a role in electron transfer across the BMC shell. Alternatively it 
has been proposed that its function is to rebuild [Fe-S] centres in the lumen of the 
BMC (Crowley et al., 2010). Deletion of pduT does not prevent formation of BMCs 
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suggesting that its role is non-essential for BMC formation. Similarly the growth rate 
of mutants lacking PduT is not impaired (Cheng and Bobik, 2010; Cheng et al., 
2011). 
1.3.5.9. Shell protein composition of the 1,2-propanediol utilising BMC 
 
The relative ratios between different shell proteins are key to understanding their 
function with regard to the structural characteristics of the BMC shell. A study 
utilising 2D gel electrophoresis, peptide mass fingerprinting and densitometry has 
allowed for accurate determination of the relative ratios between shell proteins in S. 
enterica (Havemann and Bobik, 2003). Shell proteins make up 48.1 % of the total 
protein content of purified BMCs, the remainder being encapsulated and associated 
proteins. 
 
The majority of the BMC shell is composed of PduB and its shorter isoform PduB’, 
25.6 % and 25.2 % of the total protein, respectively. PduA and PduJ share a high 
level of sequence similarity (86 %) and make up 15.6 % and 22.9 % of the shell 
protein, respectively. PduK, PduT and PduU make up minor components of the 
shell, 3.3 %, 3.3 % and 3.1 %, respectively, as determined by densitometry (Table 
1) (Havemann and Bobik, 2003). Protein spots for PduN were not detected in this 
study, presumably because of its low abundance (Parsons et al., 2010). 
 









Table 1. Shell protein composition of purified 1,2-propanediol utilizing BMCs. 
Modified from  (Havemann and Bobik, 2003). 
 
A recent study examining the protein composition of 1,2-PD utilizing BMCs from C. 
freundii has revealed a similar protein composition with PduB and PduB’ making up 
18 % and 31 % of the total shell protein, respectively. In this study PduN was 
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detected and as expected was found to make up a minor component of the shell 
(2%) (Mayer et al., 2016). 
 
1.3.6. Principles for BMC assembly  
 
The essential structural components of BMCs have been known for some time for 
example PduB, PduJ and PduK in the BMC associated with propanediol utilization 
(Parsons et al., 2010; Cheng et al., 2011). However the nature by which BMC 
components come together has been relatively poorly understood. Early TEM 
analysis of Anabaena variabilis suggested that the shell of the carboxysome formed 
first and was subsequently packed with encapsulated protein, although it should be 
noted the structures observed do not resemble BMC facets (Price and Badger, 
1991). However, this leaves the obvious problem: how does cargo protein get 
encapsulated into a closed structure? 
 
A recent study utilizing TEM and confocal analyses has shown that the formation of 
β-carboxysomes in the organism Synechococcus elongatus do in fact form from the 
inside out, i.e. the core of enzymes forms first and this protein aggregate is then 
encapsulated within the shell. The ordered assembly of carboxysomes proceeds as 
follows: 
 
RuBisCO first aggregates, in a process dependent on full (M58) and short (M35) 
length CcmM, forming a procarboxysome aggregate. CcmN is then recruited to this 
procarboxysome through interactions with CcmM. The C-terminal targeting peptide 
on CcmN then recruits the shell components CcmK2 and CcmO, with the 
encapsulation of this aggregate by incorporation of the pentameric vertex protein the 
functional carboxysome then buds off the procarboxysome body (Cameron et al., 
2013). 
 
Conversely, electron tomograms of Halothiobacillus neapolitanus reveals the 
presence of partially formed α-carboxysomes suggesting the co-assembly of the 
shell with encapsulated enzymes (Iancu et al., 2010). Deletion of RuBisCO results in 
the presence of regularly shaped carboxysomes suggesting that it is not key to the 
formation of organelles (Menon et al., 2008). 
 
To date, the formation of metabolosomes has not been revealed however it should 
be noted that the formation of these BMCs is not dependent on the presence of a 
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protein to be encapsulated as evidence has shown that it is possible to 
recombinantly produce empty BMCs (Parsons et al., 2010; Sutter et al., 2017). 
 
1.3.7. Targeting to BMCs 
 
The functionality of BMCs is only provided when specific enzymes are encapsulated 
within the shell. Sequence alignments of the PduCDE diol dehydratase revealed 
that two of the subunits contain N-terminal extensions that are not present in 
homologues that are not associated with BMCs, with further analysis revealing that 
these extensions are not required for enzymatic activity (Daniel et al., 1998; 
Tobimatsu et al., 2005). Similarly sequence alignments showed that the N-terminal 
region of PduP is not present in homologues and is similarly not required for 
enzyme function (Fan et al., 2010). Fan et al showed it was possible to localize GFP 
and other proteins to BMCs by transplanting the N-terminal 18 amino acids of PduD 
and PduP onto the N-terminus of the reporter protein, thereby opening up the 
possibility of re-functionalizing these nanoreactors (Fan et al., 2010; Fan and Bobik, 
2011). The solution structure of the PduP targeting peptide has recently been solved 
by NMR spectroscopy, revealing as previously predicted an amphipathic alpha helix 
(Lawrence et al., 2014). 
 
It has been shown that it is possible to utilize targeting sequences from different 
BMC systems to target proteins to the Pdu BMC, for example fusion of the first 20 
amino acids of EutC to GFP showed localization to the Pdu BMC (Jakobson et al., 
2015). This promiscuity for targeting sequences suggests a relatively simple 
targeting mechanism. Sequence analysis reveals a common hydrophobic motif 
facilitates protein encapsulation into BMCs (Jakobson et al., 2015). This revelation 
has allowed for the design of novel targeting sequences based upon this 
hydrophobic motif that allow for targeting to BMCs (Jakobson et al., 2017a). 
However these ‘novel’ targeting peptides likely bind to the same site on the BMC 
shell as the native peptides, therefore limiting their functionality. The development of 
a truly novel system for the targeting of proteins to BMCs would allow for much 
tighter control over the ratios of encapsulated components. 
 
It must also be noted that the majority of encapsulated proteins do not contain an 
obvious amphipathic targeting sequence and therefore other protein-protein 
interactions must be key to the encapsulation of such components and the formation 
of functional BMCs. 
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Previous experimental evidence has shown that the PduP targeting peptide 
interacts with the shell proteins PduA, PduJ and PduK (Fan et al., 2012; Lawrence 
et al., 2014). Alanine mutagenesis of 5 conserved C-terminal residues of PduA 
showed that H81A, V84A and L88A resulted in reduced targeting of PduP to BMCs 
suggesting that these residues likely interact with the PduP targeting peptide, 
importantly it should be noted that these residues are located on the concave 
surface of PduA (Havemann et al., 2002; Fan et al., 2012). Targeting was likely not 
completely eliminated presumably because of the sequence similarity between 
PduA and PduJ, including conservation of the three critical C-terminal residues (Fan 
et al., 2012). 
 
Intriguingly the crystal structure of the H. ochraceum BMC reveals that the concave 
face of the hexameric protein, containing the C-terminus faces out (Sutter et al., 
2017). If this organisation is conserved among BMCs, which is likely due to the high 
level of conservation this suggests either that PduP binds solely to the exterior 
surface of the BMC shell or that there are multiple binding sites for this protein. 
 
1.3.8. Recombinant production of BMCs 
 
The first BMC to be recombinantly produced was the metabolosome associated with 
1,2-propanediol utilization. Through the transfer and expression of the 21 gene pdu 
operon from C. freundii into E. coli functional BMCs were produced and visualised 
(Parsons et al., 2008). Further work has shown that it is possible to recombinantly 
produce empty Pdu BMCs through the expression of a minimal set of 6 shell 
proteins, PduA, B, B’, J, K and N, although slightly larger structures are formed with 
the addition of PduU, opening up the possibility of re-functionalising these 





Figure 7. TEM analysis of purified empty BMCs produced through the expression of 
PduABB’JKNU in BL21 * (DE3) cells and subsequent purification. Scale bar shows 
100 nm (Lee, M.J. unpublished). 
 
Several attempts have been made to recombinantly produce Eut BMCs, however to 
date, all such attempts have resulted in-vivo aggregates, it has also been claimed 
that a single hexameric shell protein is ample for the formation of BMCs, however 
these structures appear in micrographs to resemble membranous vesicles  
(McBroom et al., 2006; Choudhary et al., 2012; Held et al., 2016; Quin et al., 2016). 
 
More recently functional carboxysomes have been successfully produced in E. coli 
through the expression of the 10-gene operon encoding α-carboxysomes from H. 
neapolitanus. Upon induction, icosahedral structures were visualised by TEM that 
appear structurally similar to those of the host, the functionality of these CO2 fixing 
organelles was also shown (Bonacci et al., 2012). However under high protein 
induction, inclusion bodies were seen as well as filamentous structures, suggesting 
an imbalance in protein stoichiometry (Bonacci et al., 2012). 
 
A BMC of unknown function has recently been recombinantly expressed in E. coli. A 
synthetic operon containing the seven-shell protein encoding genes from 3 
chromosomally separated loci in H. ochraceum was constructed and recombinantly 
expressed in E. coli (Lassila et al., 2014). BMCs could be readily purified and 
formed uniform 40 nm structures, however these could not be visualized in-vivo 
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suggesting that they form during the purification process (Lassila et al., 2014; Sutter 
et al., 2017). Intriguingly, the pentameric vertex protein was not required for the 
formation of BMCs (Lassila et al., 2014). The functionality of this BMC remains 
unclear however the presence of an aldehyde dehydrogenase suggests that this 
BMC facilitates the sequestration of a toxic aldehyde intermediate like many other 
BMCs (Yeates et al., 2010; Axen et al., 2014). 
 
1.3.8.1. Protein nanotubes 
 
It has been shown that recombinant expression of the C. freundii hexameric protein 
PduA in E. coli results in the formation of proteinaceous filaments (Parsons et al., 
2010). Further analysis of these structures reveals that they have an external 
diameter of approximately 20 nm (Figure 8) (Pang et al., 2014). Mutation of residues 
predicted to be involved in nanotube assembly, lysine 26 and arginine 79 to alanine 
resulted in the formation of sheet like structures in the cytoplasm of transformed 
cells (Pang et al., 2014). A homologous protein to PduA, RmmH from 
Mycobacterium smegmatis similarly forms nanotubes when over expressed in E. 
coli, however these nanotubes have a smaller external diameter (14 nm), however, 
this diameter increased upon purification to 18 nm (Noël et al., 2016). The increase 
in diameter may be due to the collapsing of the nanotubes as they are dried onto 
TEM grids.  
 
 
Figure 8. TEM analysis of E. coli overexpressing PduA* from C. freundii in 
transverse (a) and longitudinal (b) thin sections. Scale bar in b shows 0.5 µm (Pang 
et al., 2014). 
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The functionalisation of these protein nanotubes and sheet like structures may allow 
for increased localised intermediate concentrations and therefore greater flux 
through an engineered metabolic pathway without the great cost on the cell of 
producing a BMC. 
 
1.4. Spatial organisation in synthetic biology 
 
Synthetic biologists have long looked to nature to develop strategies to enhance 
synthetic metabolic pathways. This has brought BMCs into the fore as they present 
the potential to both increase local concentrations of enzymes and intermediates 
and also prevent the release of toxic intermediates from engineered metabolic 
pathways. 
 
To date the utilisation of BMCs for industrial applications has been limited primarily 
by the difficulties in recombinantly producing empty BMCs in-vivo (Choudhary et al., 
2012; Lassila et al., 2014; Sutter et al., 2017). Despite this, significant progress has 
been made towards the industrial use of BMCs. 
 
1.4.1. BMC technology for fine and commodity chemical production 
 
The first, and at present, only example of the repurposing of a BMC for a 
biotechnological application was performed in 2014. An ethanol bioreactor was 
formed through the co-expression of the genes required to form an empty BMC with 
pyruvate decarboxylase and alcohol dehydrogenase tagged with targeting peptides 
(Lawrence et al., 2014). These recombinant bioreactors produced more ethanol in 
comparison to strains producing untagged enzymes with BMCs, however, as 
subsequently revealed the fusion of targeting peptides onto recombinant proteins 
results in protein aggregation and increased pathway flux (Lee et al., 2016). It is 
therefore unclear if the increase in ethanol production was as a result of the 
encapsulation of the pathway or the aggregation of the pathway.  
 
The utilisation of cellular aggregates for the enhancement of recombinant metabolic 
pathways also shows promise; by simply tagging the 4 enzymes for the synthesis of 
1,2-PD from glycerol in the absence of BMCs a 245% increase in product formation 
was observed in comparison to a strain expressing untagged soluble enzymes (Lee 
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et al., 2016). This increase in production is likely due to substrate channelling within 
the polar inclusion bodies.  
 
The development of novel targeting mechanisms that avoid the problem of 
amphipathic targeting peptides resulting in protein aggregation would allow for the 
efficient utilisation of this technology. To date the development of novel targeting 
mechanisms has been limited to re-engineering existing targeting peptides that 
share the same hydrophobic motif, and will therefore likely bind to the same region 
on the BMC shell although the interaction domain for targeting peptides on the shell 
has not yet been experimentally shown (Jakobson et al., 2015; Jakobson et al., 
2017a). Recently, researchers have utilised the non-native protein interaction 
domains to target fluorescent proteins to recombinant BMCs in Corynebacterium 
glutamicum, however, such fusions also appear to result in protein aggregation 
within the cell (Huber et al., 2017). 
1.4.2. Bioremediation 
 
The removal of polyphosphate from wastewater is a key step in wastewater 
treatment (Grady Jr et al., 2011). Currently wastewater treatment plants utilize a 
complex bacterial community to remove polyphosphate from wastewater (Mino, 
2000; Gebremariam et al., 2011). Due to their ability to sequester molecules away 
from the cytoplasmic machinery, BMCs were proposed as a potential technology to 
facilitate the removal and storage of polyphosphate. 
 
Recently researchers have attempted to engineer a compartment to remove 
polyphosphate. This was achieved by encapsulating polyphosphate kinase with a 
targeting peptide resulting in its encapsulation and the build up of polyphosphate 
within the BMC. Expression of an exopolyphosphatase did not result in the 
degradation of polyphosphate suggesting that it is sequestered within BMCs (Liang 
et al., 2017). 
 
1.4.3. Carbon/ nitrogen fixation in C3 plants 
 
As discussed previously cyanobacteria utilize a carbon concentrating mechanism 
(CCM) to enhance carbon fixation (Kerfeld and Melnicki, 2016). The transplantation 
of this functionality to plants has the potential to increase global carbon fixation as 
well as to increase productivity (Zarzycki et al., 2013). The inefficient enzyme 
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RuBisCO is known to account for approximately 50% of the soluble protein in C3 
plants, therefore reducing the amount of RuBisCO required by increasing the 
efficiency has the potential to enhance yields (Price et al., 2008).  
 
Towards this goal, researchers have been able to form β-carboxysome like 
structures in Nicotiana benthamiana chloroplasts by expression of 3 proteins 
(CcmO-YFP, CcmK2 and CcmL-YFP or CcmM58-YFP), however similar structures 
are not seen in the absence of YFP fusions and as such further work is required to 
probe these in-vivo structures (Lin et al., 2014).  
 
1.5. Aims and objectives 
 
Herein, we aim to utilise BMC technology to enhance the subcellular organisation of 
proteins through a number of strategies.  
 
First, through the utilisation of the BMC targeting peptides derived from PduD and 
PduP we show that recombinant proteins fused to these peptides aggregate in-vivo, 
and that these protein aggregates enhance production of the commodity chemical 
1,2-PD. 
 
Furthermore, we analysed the sequence of a diverse set of targeting peptides and 
found a common hydrophobic motif that is highly conserved, this motif and its 
application for the production of commodity chemicals form the basis of a patent. 
 
Third we utilise a three-component system to functionalize PduA nanotubes to form 
an in-vivo filamentous network that proteins can be targeted to. 
 
Finally we aimed to develop a BMC system that would allow for the targeting to both 
the luminal face as well as the exterior of surface of the BMC through the application 
























Publications listed in this chapter are contained within the Appendix; contributions to 

















2.1. Employing bacterial microcompartment technology to engineer a 
shell-free enzyme-aggregate for enhanced 1,2-propanediol production 
in Escherichia coli. 
 
Lee, M.J., Brown, I.R., Juodeikis, R., Frank, S., and Warren, M.J. (2016) Employing 
bacterial microcompartment technology to engineer a shell-free enzyme-aggregate 




Bacterial microcompartments (BMCs) enhance the breakdown of metabolites such 
as 1,2-propanediol (1,2-PD) to propionic acid. The encapsulation of proteins within 
the BMC is mediated by the presence of targeting sequences. In an attempt to 
redesign the Pdu BMC into a 1,2-PD synthesising factory using glycerol as the 
starting material we added N-terminal targeting peptides to glycerol dehydrogenase, 
dihydroxyacetone kinase, methylglyoxal synthase and 1,2-propanediol 
oxidoreductase to allow their inclusion into an empty BMC. 1,2-PD producing strains 
containing the fused enzymes exhibit a 245% increase in product formation in 
comparison to un-tagged enzymes, irrespective of the presence of BMCs. Tagging 
of enzymes with targeting peptides results in the formation of dense protein 
aggregates within the cell that are shown by immuno-labelling to contain the vast 
majority of tagged proteins. It can therefore be concluded that these protein 









2.1.2. Context of research 
 
Substrate channelling can occur by either the direct transfer of a substrate between 
active sites of enzymes or through an increased local concentration of enzymes and 
substrates (Spivey and Merz, 1989). Bacterial microcompartments are thought to 
increase local concentrations of enzymes and intermediates. Additionally the 
presence of a semi permeable protein shell may act to protect the cell from toxic 
pathway intermediates and prevent the loss of intermediates to side reactions 
(Yeates et al., 2010).  
 
Synthetic biologists are evermore looking to BMCs as a chassis to enhance 
production of both fine and commodity chemicals. Industrial applications of BMCs 
have become apparent through the recombinant expression of BMCs and the 
generation of empty BMCs by expression of a minimal set of shell proteins (Parsons 
et al., 2008; Parsons et al., 2010). The encapsulation of proteins within BMCs is 
mediated by short targeting peptides; such targeting peptides have been previously 
utilized to target fluorescent proteins to BMCs (Fan et al., 2010; Fan and Bobik, 
2011).  
 
Previously it has been shown that co-expression of pyruvate decarboxylase and 
alcohol dehydrogenase tagged with targeting peptides with the genes required to 
form empty BMCs resulted in the production of an ethanol bioreactor (Lawrence et 
al., 2014). This initial study showed the industrial potential of BMC technology. 
 
Here, we aimed to construct a bioreactor for the production of 1,2-PD utilizing the 
feedstock glycerol, a compound that is produced as a by-product of biodiesel 
production (Marchetti et al., 2007). 1,2-propanediol, a commodity chemical currently 
used in the production of antifreeze, thermoset plastics and cosmetics, is currently 
produced from non-renewable resources. Annual demand for this compound was 
estimated in 2011 to be 1.36 million tonnes and it is therefore of great interest to 








2.1.3. Aims of research 
 
This research aimed to target a longer metabolic pathway to BMCs than has 
previously been achieved. We chose a 5-step pathway for the production of 1,2-PD 
from glycerol. The selection of this pathway was based on knowledge that 1,2-PD 
should be able to get into the BMC as it is the substrate for the wild type organelle 
and we presume it can therefore also diffuse out of the structure.  
 
The aim of this work was to create an in-vivo propanediol bioreactor, which we 
sought to achieve by tagging four enzymes: glycerol dehydrogenase, 
dihydroxyacetone kinase, methylglyoxal synthase and 1,2-propanediol 
oxidoreductase. These enzymes form a pathway that is able to convert glycerol to 
1,2-propanediol. The pathway involves the toxic intermediates methylglyoxal and 
lactaldehyde and therefore we propose that encapsulation of this pathway within a 























2.2. Patent application: Genetically modified microorganisms. 
 
Lee, M.J., Frank, S. Warren, M.J. 2015. Genetically Modified Microorganisms. Filed 




The present invention relates to genetically modified microorganisms and their use 
in the production of desired products of metabolic pathways, and particularly 
improving the levels of production of said products.  In particular the microorganisms 
of the present invention are modified to comprise enzymes of a metabolic pathway 
for a product of interest, wherein the enzymes are each tagged with a bacterial 
microcompartment (BMC)-targeting signal peptide, and wherein the microorganism 
lacks bacterial microcompartments.  The present invention also relates to cell-free 
systems comprising said (BMC)-targeting signal peptide tagged enzymes in the 
absence of BMCs. 
 
2.2.2. Context of research 
 
This patent application concerns the use of bacterial microcompartment targeting 
peptides for the production of both commodity and fine chemicals. The requirement 
for fossil fuel derived products is ever increasing; therefore many industrial sectors 
are investigating methods to overcome this reliance of fossil fuels through the 
development of more efficient pathways.  
 
 
2.2.3. Aims of research 
 
Here we aimed to protect our finding that BMC targeting peptides fused to enzymes 
of a synthetic metabolic pathway enhance productivity of pathways by aggregation 
of enzymes into an active inclusion body. 
 
The experimental data presented in this patent application is the same as in the 
publication ‘Employing bacterial microcompartment technology to engineer a shell-
free enzyme-aggregate for enhanced 1,2-propanediol production in Escherichia 
coli.’  
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2.3. Engineered synthetic scaffolds for organising proteins within 
bacterial cytoplasms 
 
Lee, M.J., Mantell, J., Hodgson, L., Alibhai, D., Fletcher, J.M., Brown, I.R., Frank, S., 
Xue, W-F., Verkade, P., Woolfson, D.N., Warren, M.J. (2018) Engineered synthetic 




We have developed a system for producing a supramolecular scaffold that 
permeates the entire Escherichia coli cytoplasm. This cytoscaffold is constructed 
from a three-component system comprising a bacterial microcompartment shell 
protein and two complementary de novo coiled-coil peptides. We show that other 
proteins can be targeted to this intracellular filamentous arrangement. Specifically, 
the enzymes pyruvate decarboxylase and alcohol dehydrogenase have been 
directed to the filaments, leading to enhanced ethanol production in these 
engineered bacterial cells compared to those that do not produce the scaffold. This 
is consistent with improved metabolic efficiency through enzyme colocation. Finally, 
the shell-protein scaffold can be directed to the inner membrane of the cell, 
demonstrating how synthetic cellular organization can be coupled with spatial 
optimization through in-cell protein design. The cytoscaffold has potential in the 
development of next-generation cell factories, wherein it could be used to organize 








2.3.2. Context of research 
 
The localisation of proteins on scaffolds to enhance metabolic pathways has gained 
significant attention in recent years. Researchers have investigated bacterial 
microcompartments, protein-based scaffolds, lipids and DNA scaffolds as facilitators 
of enhanced enzyme localisation (Dueber et al., 2009; Grinkova et al., 2010; 
Delebecque et al., 2012; Lawrence et al., 2014). Despite advances in the field, and 
with the exception of bacterial microcompartments, to date it has not been possible 
to produce a visible protein scaffold within the bacterial cytoplasm that allows for the 
tethering of enzymes. The overexpression of the BMC shell protein PduA has been 
shown to form proteinaceous filaments in-vivo (Parsons et al., 2010). These 
filaments, approximately 20 nm in diameter and several microns in length have been 
previously characterised and modified to form a variety of in-vivo structures (Pang et 
al., 2014). Recent work has shown that it is possible to target fluorescent proteins to 
PduA* nanotubes by fusion to BMC targeting peptides in Corynebacterium 
glutamicum (Huber et al., 2017). The authors also show that it is possible to target 
to these structures via C-terminally fused protein interaction domains. However the 
structures visualised by fluorescence microscopy appear to be bundles of filaments 
as formed by untagged PduA. This bundling limits the accessible surface area and 
thus limits the biotechnological applications of such structures.  
 
Here we aim to enhance subcellular organisation by targeting recombinant proteins 
to engineered cytoplasmic scaffolds or cytoscaffolds. By targeting enzymes of a 
metabolic pathway to these protein filaments we propose that local concentrations 
of both enzymes and substrates would be increased thereby leading to increased 
pathway productivity. 
 
2.3.3. Aims of research 
 
The aim of the work presented in this publication was to engineer a bacterial 
scaffold based on the BMC shell protein PduA. We set out to utilize a pair of 
complementary coiled-coil peptides to target recombinant proteins to these protein 
filaments by attaching one peptide to the BMC shell protein PduA and the cognate 
peptide to a protein of interest.  
 
We aimed to functionalise these nanotubes with pyruvate decarboxylase and 
alcohol dehydrogenase, enzymes that facilitate the conversion of pyruvate into 
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ethanol to investigate if localisation of enzymes on a nanotube provides an 
enhancement to pathway productivity. 
 
Furthermore utilising this coiled-coil technology and a C-terminal membrane 
targeting peptide we aim to target this scaffold to the inner membrane of the cell. 
This specific localisation may improve pathway flux due to the increased proximity to 






























2.4. De novo targeting to the cytoplasmic and luminal side of bacterial 
microcompartments 
 
Lee, M.J., Brown, I.R., Fletcher, J.M., Pickersgill, R.W., Woolfson, D.N., Frank, S., 
Warren, M.J. De novo targeting to the cytoplasmic and luminal side of bacterial 




Bacterial microcompartments, BMCs, are proteinaceous organelles that encase a 
specific metabolic pathway within a semi-permeable protein shell. Short 
encapsulation peptides direct cargo proteins to the lumen of the compartments. 
However, the fusion of such peptides to non-native proteins does not guarantee 
encapsulation and often causes aggregation. Here, we report a different approach 
for targeting recombinant proteins to BMCs that utilizes specific de novo coiled-coil 
protein-protein interactions. Attachment of one coiled-coil module to a component of 
the bacterial microcompartment shell, PduA, allows targeting of a fluorescent protein 
marker fused to a cognate coiled-coil partner. This interaction takes place on the 
outer surface of the BMC. The redesign of PduA to generate a new N-terminus on 
the luminal side of the BMC results in intact compartments to which fluorescent 
proteins can still be targeted via the designed coiled-coil system. This study 
demonstrate that de novo coiled-coil peptide technology can be used to target to the 
luminal or cytoplasmic faces of BMCs, allowing proteins to be displayed on the 








2.4.2. Context of research 
 
A major obstacle to the employment of BMCs in industrial applications is the 
problem of aggregation as a result of fusions between enzymes and BMC targeting 
peptides (Lee et al., 2016). Despite the fact that we have shown that aggregation of 
an engineered metabolic pathway is advantageous there may be applications that 
require a further sequestered environment and thus an effective alternative targeting 
system would be required. For example encapsulation of recombinantly produced 
toxic proteins may enhance their production. 
 
Previous work has shown that fusion of the protein interaction domains to the C-
terminus of PduA and co-expression of a fluorescent protein tagged with the 
interaction partner results in the fluorescent protein being localised to the poles of 
the cell, suggesting that the fluorescent protein is aggregating (Huber et al., 2017). 
Here we aim to develop an altogether different strategy utilising a pair of de novo 
designed coiled-coil peptides to target proteins to recombinantly produced BMCs. 
 
2.4.3. Aims of research 
 
The aim of this work was to overcome problematic protein aggregation by designing 
a novel mechanism for targeting proteins to BMCs. As with previous work we aimed 
to utilise a pair of complementary coiled-coil peptides to facilitate targeting. One half 
of the heterodimeric pair would be fused to a major component of the Pdu BMC 
shell, PduA, and the cognate peptide would be fused to a protein of interest. The 
coiled-coil interaction would then facilitate targeting of the protein of interest to the 
BMC. 
 
Furthermore we aimed to re-engineer a BMC shell protein to enable targeting to 
both the internal and external face of the structure. We aimed to achieve this 










































3.1. Employing bacterial microcompartment technology to engineer a 
shell-free enzyme-aggregate for enhanced 1,2-propanediol production 
in Escherichia coli. 
 
The work presented in this paper shows a broad range of results with a number of 
further applications. First, we show that encapsulation of GFP with a C-terminal 
proteolysis tag within a BMC protects it from proteolysis by ClpAP and ClpXP 
whereas the same GFP in the absence of BMCs is effectively degraded. This result 
reinforces previous evidence that shows the shell of the BMC acts as a semi-
permeable membrane and provides an effective barrier between encapsulated and 
cytoplasmic proteins.  
 
This research shows how the fusion of the targeting peptides D18 and P18 to the 
enzymes required for the conversion of glycerol to 1,2-PD results in protein 
aggregation. The amphipathic nature of BMC targeting peptides is thought to be the 
cause of this aggregation. Furthermore expression of all of the enzymes of the 
engineered pathway resulted in the appearance of large polar enzyme aggregates. 
Unexpectedly the data shows that an increase in product formation was not 
dependent on the presence of BMCs and the tagging of enzymes with targeting 
peptides was sufficient to significantly enhance 1,2-PD production, suggesting that 
the localisation of proteins to the inclusion facilitates enhanced product formation. 
 
The work presented in this publication shows how bacterial microcompartment 
targeting peptides can be utilized to form intracellular enzyme aggregates that 
contain the enzymes required to convert glycerol to 1,2-PD. Due to the simple 
nature of these peptide fusions this technology has the potential to be applicable to 












3.2. Patent application: Genetically modified microorganisms. 
 
Sequence alignments of enzymes known to be associated with BMCs have 
revealed a highly conserved hydrophobic motif that is absent from non-
encapsulated enzymes and it is this hydrophobic motif that facilitates protein 
encapsulation into BMCs. We show experimentally that fusions between proteins 
and such peptides result in aggregation of such proteins and that these enzyme 
aggregates confer enhanced pathway productivity. This patent seeks to protect the 
use of such peptides containing this conserved hydrophobic motif in pathways 



























3.3. Engineered synthetic scaffolds for organising proteins within 
bacterial cytoplasms 
 
Here we demonstrate how an intracellular scaffold can enhance spatial organisation 
in E. coli. This scaffold is constructed from a BMC shell protein, PduA, and a pair of 
complementary coiled-coil peptides. We show that fusion of CC-Di-B to PduA* 
results in the formation of a dispersed network of filaments that permeates the entire 
cytoplasm. This network of filaments that we observe with CC-Di-B-PduA* provides 
a high surface area exposed to cytoplasmic substrates therefore providing 
enhanced potential over the bundled PduA* structures. We show that co-expression 
of CC-Di-A tagged fluorescent proteins with the CC-Di-B-PduA* scaffold result in 
their localisation to the filaments. We show functionality of this scaffold by 
appending the enzymes for ethanol production to it resulting in a significant 
enhancement in ethanol production. We also show that by lining the inner 
membrane with the CC-Di-A peptide the CC-Di-B-PduA* nanotubes can be localised 
to the membrane potentially allowing for faster exchange of metabolites and 


























Our results show that the fusion of the coiled-coil peptide CC-Di-B to PduA does not 
impair BMC formation and the resulting BMCs appear to be of similar dimensions to 
unmodified empty BMCs. Furthermore we show that by expressing fluorescent 
proteins tagged with a complementary peptide, CC-Di-A, such proteins can be 
recruited to BMCs. Structural evidence suggests that the convex side of BMC shell 
proteins faces the lumen and therefore the concave side containing the N and C-
termini of PduA face out suggesting that the fusions that we have constructed label 
the outer surface of the structure (Sutter et al., 2017). The accessibility of coiled coil 
peptides on the outer surface of BMCs could allow for a metabolic pathway to be 
split between the outer surface and luminal space. Or alternatively, more 
significantly, it could be used to direct BMCs to specific areas of the cell for example 
by targeting bioreactors to the membrane of the cell thereby increasing channelling 
of substrates from the extracellular environment into the bioreactor. We also show 
that by circularly permuting the BMC shell protein PduA it is possible to target 




















3.5. Concluding remarks 
 
The aim of this research was to enhance spatial organisation in E. coli. Through 
deconstruction of the BMC associated with 1,2-PD utilisation, and the utilisation of 
the component parts, novel architectures have been produced that facilitate 
enhanced metabolic channelling. First we show how fusions between enzymes and 
BMC targeting peptides results in the formation of active enzyme aggregates that 
enhance the production of the commodity chemical 1,2-PD. Second we show how a 
three component system consisting of a bacterial microcompartment shell protein 
and a pair of complementary coiled-coil peptides can be utilised to form a 
cytoscaffold that can be functionalised. Finally, utilising the same coiled-coil 
technology we show targeting to recombinantly produced BMCs, furthermore we re-
engineer a BMC shell protein to enable targeting to both the inner and outer surface 
of BMCs. In conclusion, the data presented in this thesis offers a number of 
strategies going forward to enhance protein organisation in-vivo, allowing for higher 
order cellular design in prokaryotes. 
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a b s t r a c t
Bacterial microcompartments (BMCs) enhance the breakdown of metabolites such as 1,2-propanediol
(1,2-PD) to propionic acid. The encapsulation of proteins within the BMC is mediated by the presence of
targeting sequences. In an attempt to redesign the Pdu BMC into a 1,2-PD synthesising factory using
glycerol as the starting material we added N-terminal targeting peptides to glycerol dehydrogenase,
dihydroxyacetone kinase, methylglyoxal synthase and 1,2-propanediol oxidoreductase to allow their
inclusion into an empty BMC. 1,2-PD producing strains containing the fused enzymes exhibit a 245%
increase in product formation in comparison to un-tagged enzymes, irrespective of the presence of BMCs.
Tagging of enzymes with targeting peptides results in the formation of dense protein aggregates within
the cell that are shown by immuno-labelling to contain the vast majority of tagged proteins. It can
therefore be concluded that these protein inclusions are metabolically active and facilitate the significant
increase in product formation.
& 2016 The Authors. Published by Elsevier Inc. On behalf of International Metabolic Engineering Society.
This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
1. Introduction
Metabolic engineering involves the design and redesign of
pathways and their deployment in organisms in which they do not
naturally exist. This approach allows pathway fluxes, together with
substrate and intermediate concentrations, to be manipulated by
variation of the network parameters, which can be quantified by
metabolic control analysis (Woolston et al., 2013). However, for
pathways involving particularly volatile, unstable or toxic inter-
mediates this tactic is likely to prove problematic. To overcome the
problem of capricious metabolites nature has evolved a variety of
solutions to ensure pathways operate efficiently without a sig-
nificant build up of pernicious intermediates. In this respect sub-
strate channelling, multienzyme complexes, metabolons and
compartmentalisation are all ways in which pathway flux is
naturally controlled (Lee et al., 2012).
In bacteria, compartmentalisation is mediated through the
deployment of bacterial microcompartments (BMCs), which are
used to address the problem of unstable or reactive intermediates
(Dou et al., 2008; Havemann et al., 2002; Penrod and Roth, 2006;
Sampson and Bobik, 2008). BMCs are proteinaceous complexes
that are composed of a semi-porous capsid shell that encases a
specific metabolic process (Cheng et al., 2008; Frank et al., 2013;
Tanaka et al., 2008; Yeates et al., 2008). The widespread dispersal
of BMCs in 23 bacterial phyla mediated through horizontal gene
transfer suggests that pathway enhancement through employ-
ment of these structures provides a strong evolutionary benefit
(Axen et al., 2014). There are two broad classes of BMCs, car-
boxysomes and metabolosomes, which are associated with either
anabolic carbon fixation or catabolic carbon utilisation, respec-
tively. Metabolosomes, in particular, appear to operate pathways
that involve aldehydes as intermediates. Indeed, a recent bioin-
formatic analysis of BMC-associated operons revealed that the vast
majority of these operons encode for aldehyde and alcohol dehy-
drogenases (Axen et al., 2014). The best characterised of the
metabolosomes are those associated with 1,2-propanediol utili-
sation (Pdu) and ethanolamine utilisation (Eut), both of which
house cobalamin-dependent enzymes and encase pathways that
proceed via propanaldehyde and acetaldehyde respectively
(Chowdhury et al., 2014). Compelling evidence has been presented
that the compartments help protect the cell from toxicity asso-
ciated with a high aldehyde concentration (Brinsmade et al., 2005;
Sampson and Bobik, 2008; Cheng et al., 2011).
The ability to concentrate a specific metabolic pathway into
what is essentially a nano-bioreactor, coupled with the capacity to
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sequester toxic pathway intermediates, has brought BMCs to the
attention of synthetic biologists who view this as a tractable sys-
tem that can be redesigned to accommodate new pathways
(Chowdhury et al., 2014; Lawrence et al., 2014). Such a system has
the potential to be used to enhance the yield of commodity che-
micals produced via bacterial fermentation. Significantly, the
Citrobacter freundii Pdu BMC can be produced as an empty com-
partment through the coordinated production of only the shell
proteins (PduA, B, B0, J, K, N, U) (Parsons et al., 2010). Enzymes can
then be targeted so that they are incorporated into the BMC
through the fusion of peptide sequences that are found at the N-
terminus of proteins such as PduD (D18) and PduP (P18) (Fan et al.,
2010; Fan and Bobik, 2011). Furthermore, targeting of the Zymo-
monas mobilis pyruvate decarboxylase and alcohol dehydrogenase
resulted in the conversion of the Pdu BMC into an ethanol bior-
eactor (Lawrence et al., 2014).
Bio-product commodities that have successfully transitioned
into the market through biotechnological approaches include 1,3-
propanediol, polylactic acid (PLA) and polyhydroxyalkanoate
(PHA), which have been used for personal care products, anti-
freeze and biodegradable plastics (Adkesson et al., 2011; Jung et
al., 2010; Suriyamongkol et al., 2007). Near-term bio-based pro-
ducts, such as 1,4-butanediol, isobutanol and succinic acid are in
progress whilst systems are under development for the production
of terpenes and itaconic acid (Burk, et al., 2011; Lee et al., 2005;
Peralta-Yahyan et al., 2011, 2012; Steiger et al., 2013; Yim et al.,
2011). Approaches such as metabolic engineering and synthetic
biology are routinely applied in order to make these processes
more efficient and cost competitive. In this paper we outline a
method that offers the potential for a significant step-change in
bio-commodity production through the development of BMC
technology.
The production of 1,2-propanediol from glycerol is similarly
recognised as a commercially relevant pathway. 1,2-Propanediol is
a commodity chemical that is currently used in the production of
plasticisers, antifreeze, thermoset plastics and cosmetics with an
annual global demand estimated at around 1.36 million tonnes per
year with demand expected to increase over the next few years
(Clomburg and Gonzalez, 2011). It is, therefore, of great interest to
develop a production method that does not rely on a non-
renewable resource (Altaras and Cameron, 1999, 2000; Clomburg
and Gonzalez, 2011). Glycerol, on the other hand, is readily avail-
able as it is produced as a by-product of the biodiesel production
process (Marchetti et al., 2007). It has been reported that for every
100 kg of biodiesel produced 10 kg of glycerol is generated (Yaz-
dani and Gonzalez, 2007). The biochemical pathway for the
synthesis of 1,2-propanediol from glycerol (Fig. 1) involves the
intermediate methylglyoxal, a compound that is highly toxic to
cells in sub-millimolar concentrations (Ferguson et al., 1996). The
pathway involves four enzymes, glycerol dehydrogenase (GldA),
dihydroxyacetone kinase (DhaK), methylglyoxal synthase (MgsA)
and 1,2-propanediol oxidoreductase (FucO). Previously it has been
shown that a DNA scaffold enhances 1,2-propanediol production
in Escherichia coli from glucose with 3 enzymes including MgsA
and GldA (Conrado et al., 2012). Here we set out an alternative
approach to determine if the proposed pathway for 1,2-propane-
diol production could be enhanced through compartmentalisation
into a BMC. Moreover we present an alternative approach to
compartmentalisation that is the aggregation of enzymes into a
supramolecular conglomerate.
The aim of the investigation was therefore to set about creating
fusion proteins between known Pdu targeting peptides (D18 and
P18) and the four 1,2-propanediol producing enzymes in order to
allow their targeting to a recombinant empty Pdu BMC system.
The effect of the targeting peptides on the activity of the different
enzymes and their solubility was investigated. The ability of the
targeted enzymes to promote 1,2-propanediol synthesis was
determined. The strains were analysed by TEM and protein
aggregation was found to play an unexpected but key role in
enhancing pathway productivity.
2. Materials and methods
2.1. Plasmid construction
Plasmids were constructed to provide each of the genes of
interest with a N-terminal hexa-histidine tag with an optional D18
or P18 targeting peptide.
Fig. 1. A pathway for the synthesis of 1,2-propanediol from glycerol. Glycerol dehydrogenase and dihydroxyacetone kinase catalyse the conversion of glycerol to dihy-
droxyacetone phosphate. Methylglyoxal synthase catalyses the conversion to methylglyoxal. Glycerol dehydrogenase and 1,2-propanediol oxidoreductase catalyse the
conversion of methylglyoxal to 1,2-propanediol via the intermediate lactaldehyde.
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All primers used in this study are listed in Supplementary
Table 3. All genes were amplified with flanking NdeI and SpeI
restriction sites and each was ligated into pET14b, pET14b-D18 and
pET14b-P18 vectors using NdeI and SpeI restriction sites. Plasmids
pML-1 to pML-6 as outlined in Supplementary Table 2, were
constructed by a ‘Link and Lock’ approach utilising the compatible
sticky ends formed by digestion with XbaI and SpeI (McGoldrick et
al., 2005).
2.2. Overexpression and purification of recombinant protein
BL21 (DE3) pLysS competent cells were transformed with a
plasmid containing the gene(s) of interest. 1 L of LB supplemented
with ampicillin (100 mg/L) and chloramphenicol (34 mg/L) in
baffled flasks was inoculated from an overnight starter culture. The
cultures were grown at 37 °C with shaking for 7 h; protein pro-
duction was induced by the addition of IPTG to a final con-
centration of 400 mM. The cultures were then incubated overnight
at 19 °C with shaking. Cells were harvested by centrifugation at
3320! g for 15 minutes at 4 °C, pellets were resuspended in
20 mM Tris–HCl pH 8.0, 500 mM NaCl, 5 mM imidazole. Cells were
lysed by sonication and cell debris removed by centrifugation.
Recombinant protein was then purified from the soluble fraction
by immobilized metal ion affinity chromatography.
2.3. Activity assays
2.3.1. Glycerol dehydrogenase
The activity of GldA for the oxidation of glycerol to dihydrox-
yacetone was measured by following the initial rate of reduction of
NADþ to NADH at 340 nm. Activity assays were carried out in 1 mL
reactions containing 0.1 M potassium phosphate buffer pH 8.0,
500 μM NADþ , 2 mM MgCl2 and 200 nM GldA. The activity of
GldA for the reduction methylglyoxal to lactaldehyde, was mea-
sured by following the initial rate of the oxidation of NADH to
NADþ at 340 nm. Activity assays were carried out in 1 mL reaction
containing 0.1 M potassium phosphate pH 8.0, 0.1 mM NADH,
2 mM MgCl2 and 200 nM GldA.
2.3.2. Dihydroxyacetone kinase
The activity of DhaK for the conversion of dihydroxyacetone to
dihydroxyacetone phosphate was measured in a coupled reaction
with Glyceraldehyde 3-phosphate dehydrogenase (G3PDH) by
following the oxidation of NADH to NADþ at 340 nm. Activity
assays were carried out in 1 mL reactions containing 50 mM Tris–
HCl pH 7.5, 100 mM NaCl, 1 mM ATP, 0.1 mM NADH, 2.5 mM
MgCl2, 7.2 U G3PDH and 125 nM DhaK.
2.3.3. Methylglyoxal synthase
The activity of MgsAwas monitored in a colorimetric assay over
a time course. 25 μL of 0.5 mM MgsA was incubated in a reaction
mixture containing 400 μL 50 mM imidazole pH 7.0, 25 μL 15 mM
dihydroxyacetone phosphate and 50 μL dH2O, the reaction mix-
ture was incubated at 30 °C with shaking. At time intervals 50 μL
of the reaction mixture was removed and added to a detection
mixture containing 450 μL dH2O, 165 μL 0.1% 2,4-dini-
trophenylhydrazine hydrochloric acid solution. The detection
mixture was incubated at 30 °C with shaking for 15 min. 835 μL of
10% (w/v) NaOH was added to the detection mixture which was
incubated at room temperature for 15 minutes. Absorbance was
then measured at 550 nm.
2.3.4. 1,2-Propanediol oxidoreductase
The activity of FucO was determined for the NADH dependant
reduction of glycolaldehyde to elthylene glycol was measured by
following the initial rate of the oxidation of NADH to NADþ at
340 nm. Activity assays were carried out in 1 mL reactions con-
taining 100 mM Hepes pH 7.5, 10 μM NADH, 100 μM MnCl2 and
200 nM FucO.
2.4. Culture medium and conditions for 1,2-propanediol production
The culture medium designed by Neidhardt et al. (1974) was
supplemented with 30 g/L glycerol, 10 g/L tryptone and 5 g/L yeast
extract. Strains were cultured in sealed serum bottles with a
working volume of 100 mL at 28 °C with shaking. Cultures were
inoculated from starter cultures to a starting OD600 of 0.05. During
growth 1 mL samples were removed at 0, 6, 12, 24, 48, 72 and 96 h
for analysis of 1,2-propanediol content.
2.5. Western blot analysis
Nitrocellulose membranes following transfer and blocking
were incubated in primary antibody (mouse anti-His (Sigma
Aldrich) 1:3000 or mouse anti-GFP (Sigma Aldrich) 1:1000) fol-
lowed by incubation in a secondary coupled antibody coupled to
alkaline phosphatase (Anti-Mouse IgG (HþL), AP Conjugate (Pro-
mega) 1:5000). Bands were visualised by incubation in substrate
5-bromo-4-chloro-3-indolyl phosphate/nitro blue tetrazolium
(BCIP/NBT).
2.6. Analysis of 1,2-propanediol production
In-vivo 1,2-propanediol production was determined by GC/MS
analysis of the growth medium at time intervals (0, 6, 12, 24, 48, 72
and 96 h). The supernatant after centrifugation, was boiled for
10 min at 100 °C followed by centrifugation at 19,750! g. The
sample was then acidified with trifluoroacetic acid to a final con-
centration of 0.01% followed by a second centrifugation at
19,750! g. The supernatant following centrifugation was diluted
1:4 in acetonitrile for GC/MS analysis.
2.7. Visualisation of engineered strains
2.7.1. Embedding of strains for TEM analysis
Strains were embedded, sectioned and stained as described in
supplementary information.
2.7.2. Embedding of strains for immunolabelling
Strains were cultured as described previously (Section 2.4)
overnight, cells were harvested by centrifugation for 10 min at
3000! g. The cell pellet was resuspended in 2% formaldehyde and
0.5% gluteraldehyde in 100 mM sodium cacodolate pH 7.2 and
incubated for 2 h with gentle rotating. Cells were pelleted by
centrifugation at 6000! g for 2 min and were washed twice for
10 min with 100 mM sodium cacodylate pH 7.2. This was followed
by dehydration of the samples in an ethanol gradient, 50% EtOH
for 10 min, 70% EtOH for 10 min, 90% EtOH for 10 min, followed by
three 15 min washes in 100% EtOH. Cell pellets were then resus-
pended in 2 mL LR white resin and incubated overnight with
rotation at room temperature after which the resin was changed
and incubated for a further 6 h. Cell pellets were resuspended in
fresh resin and transferred to 1 mL gelatine capsules and cen-
trifuged at 4000! g to pellet the cells at the tip. Samples were
polymerised at 60 °C for 24 h. Samples were ultra-thin sectioned
on a RMC MT-XL ultramicrotome with a diamond knife (diatome
45°) sections (60–70 nm thick) were collected on 300 mesh
gold grids.
2.7.3. Immunolabelling of sections
Grids were equilibrated in one drop of TBST (20 mM Tris–HCl
pH 7.2, 500 mM NaCl, 0.05% Tween 20, 0.1% BSA) before being
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transferred into a drop of 2% BSA in TBST and incubated at room
temperature for 30 min. Grids were then immediately transferred
into a 20 μL drop of primary antibody (mouse anti-his (Sigma
Aldrich 1:10)) and incubated for 1 h. Grids were washed in a fresh
drop of TBST followed by washing for 10 s in a stream of TBST.
Grids were equilibrated in a drop of secondary antibody (Goat
anti-mouse IgG 10 nm gold (Agar Scientific 1:50)) then incubated
for 30 min in a fresh drop. Excess antibody was removed by
washing in two drops of TBST before washing in a stream of ddH2O
and dried.
2.7.4. Staining of immunolabelled sections
Grids were stained for 15 minutes in 4.5% uranyl acetate in 1%
acetic acid solution followed by 2 washes in dH2O. Grids were then
stained with Reynolds lead citrate for 3 min followed by a wash in
ddH2O. Electron microscopy was performed using a JEOL-1230
transmission electron microscope equipped with a Gatan multi-
scan digital camera at an accelerating voltage of 80 kV.
3. Results
3.1. Effect of targeting peptides on the activities of GldA, DhaK, MgsA
and FucO.
Recently, it has been shown that fusing the targeting peptides
D18 and P18 to heterologous enzymes, such as the Z. mobilis pyr-
uvate decarboxylase and alcohol dehydrogenase, allowed their
targeting to recombinantly produced empty BMCs, resulting in the
formation of a functional ethanol bioreactor (Lawrence et al.,
2014). However, the general effect of such fusions on functionality
of individual enzymes had not been investigated in detail. In this
study the enzymes involved in the microbial synthesis of 1,2-
propanediol from glycerol, namely glycerol dehydrogenase (GldA),
dihydroxyacetone kinase (DhaK), methylglyoxal synthase (MgsA)
and 1,2-propanediol oxidoreductase (FucO) were cloned sepa-
rately with both the D18 and P18 N-terminal targeting peptides
followed by a hexa-histidine tag. The resulting proteins were
purified by IMAC and the kinetic parameters of each of the protein
fusions were subsequently determined and compared to enzymes
containing only the N-terminal hexa-histidine tag. Herein, we
refer to the D18-His and P18-His containing proteins as ‘tagged’
enzymes and the His-only containing proteins as ‘untagged’.
The targeting peptides were found to have a highly variable
effect on the specific activities of the enzymes (Fig. 2). The first of
the enzymes, GldA, is involved in two distinct steps in the trans-
formation of glycerol to 1,2-propanediol, being responsible for the
dehydrogenation of glycerol to dihydroxyacetone as well as the
reduction of methylglyoxal to lactaldehyde. With respect to the
activity of GldA in the dehydrogenation of glycerol, the D18 tar-
geting peptide resulted in a decrease of 90% in the enzyme's
specific activity in comparison to the un-tagged control. Tagging
GldA with the P18 targeting peptide had a less dramatic effect
although the specific activity was still reduced by 55%. The tags
had a similar effect on the activity of GldA to catalyse the reduc-
tion of methylglyoxal to lactaldehyde, with the presence of D18
decreasing the specific activity by 83% whilst P18 reduced activity
by 53% (Fig. 2a). In contrast, the activity of DhaK, which catalyses
Fig. 2. The effect of targeting peptides on the specific activities of the enzymes involved in the microbial synthesis of 1,2-propanediol. (a) glycerol dehydrogenase (for the
reduction of methylglyoxal) (b) dihydroxyacetone kinase (c) methylglyoxal synthase (d) 1,2-propanediol oxidoreductase.
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the ATP dependent phosphorylation of dihydroxyacetone, was not
significantly affected by the presence of either targeting peptide
(Fig. 2b). Fusing MgsA, the methylglyoxal synthase, with either the
D18 or P18 targeting peptide had only a slight detrimental effect
on enzyme activity, decreasing the activity by 15% and 18%
respectively (Fig. 2c). The activity of FucO, the 1,2-propanediol
oxidoreductase, was found to decrease by 58% when fused to D18
but was more significantly affected by the fusion of P18, which
resulted in a 76% decrease in specific activity (Fig. 2d). It is,
therefore, interesting to note that although the D18 targeting
peptide is predicted to be structurally similar to P18, the two tags
were found to have a differential influence on the activities of the
same enzymes. From the data presented in Fig. 2 the most active
forms of the enzymes to be taken forward for inclusion into a BMC
were identified as P18-GldA, P18-DhaK, D18-MgsA and D18-FucO.
3.2. Targeting peptides cause a degree of protein aggregation
The production levels and solubility of GldA, DhaK, MgsA and
FucO, with and without targeting peptides, were investigated by
comparing samples obtained during their purification by dena-
turing polyacrylamide gel electrophoresis (Supplementary Figs.
S1–S4). DhaK and MgsA were both found to be well produced and
soluble irrespective of the presence of the D18 or P18 targeting
peptide. The solubility of FucO was, similarly, not affected by the
presence of the targeting peptides, although the yield of un-tagged
FucO appeared to be slightly lower. In contrast, even though both
P18 and D18-tagged GldA appeared to be produced and could be
purified, more of the protein was detected in the insoluble frac-
tions (Supplementary Fig. S1, lane 3). This suggests that the fusion
proteins D18-GldA and P18-GldA had a greater tendency to
aggregate in comparison to untagged GldA. Moreover, P18-GldA
was also found to elute from the IMAC column with an additional
band of lower molecular mass, indicative of partial protein
degradation.
Previous research has shown that the solubility of some of the
enzymes of both the Pdu and Eut metabolosomes is increased by
the removal of the N-terminal targeting peptides (Fan and Bobik,
2011; Shibata et al., 2010). Therefore the N-terminal peptides are
known to affect solubility. It is clear that the addition of both D18
and P18 to GldA results in a decrease in solubility, most likely
through protein aggregation. In order to investigate the aggrega-
tion behaviour of the tagged proteins in vivo, the most active
protein fusions (P18-GldA, P18-DhaK, D18-MgsA and D18-FucO)
were selected for TEM analysis of sections through whole cells. In
this respect strains encoding each of the tagged proteins were
cultured overnight without induction. Subsequently, the cells were
harvested, embedded in low viscosity resin, thin sectioned and
visualised using TEM. These were then compared to control strains
that produced the untagged protein. For each strain 100 cells were
examined and the statistical analysis of each of the strains is
shown in Fig. 3. Representative TEM micrographs were compiled
and are shown in Supplementary Fig. S5.
Control strains producing un-tagged proteins (GldA, DhaK,
MgsA, FucO) displayed a ‘normal’ phenotype, with only a max-
imum of 1% of the observed cells containing electron dense areas
that could be considered indicative of aggregated proteins. In
contrast, half of all observed cells (52%) producing P18-GldA
showed protein aggregates, which were located mainly at the
poles of the cell (Supplementary Fig. S5 B). The addition of the P18
targeting peptide to the N-terminus of DhaK resulted in aggregate
formation in 8% of the observed cells. Fusion of the D18 targeting
peptide to MgsA and FucO resulted in the presence of protein
aggregates in 12% and 4% of cells respectively. These results con-
firm that the fusions between the enzymes of the 1,2-propanediol
production pathway and the D18 and P18 targeting peptides cause
protein aggregation to various extents.
3.3. Proteins with targeting peptides are recruited to BMCs
The D18 and P18 fusion proteins were investigated for their
ability to be targeted to an empty recombinant BMC. This was
achieved by generating strains with the ability to co-express,
individually, P18-gldA, D18-dhaK, P18-mgsA and D18-fucO together
with the construct housing the genes for empty shell formation
(pLysS-pduABJKNU). After growth, the recombinant BMCs were
purified using a combination of centrifugation and differential salt
precipitation as described previously (Lawrence et al., 2014). The
isolated BMCs were then analysed by SDS PAGE for the presence of
the characteristic BMC shell–protein profile. This revealed that all
the tagged proteins co-purified with the BMC fraction to a greater
extent than untagged protein, consistent with the proteins being
encased within the BMC (Supplementary Fig. S6). This was further
confirmed by kinetic assays of the final purified BMC fraction for
the respective tagged enzymes.
To provide further evidence that the D18 and P18 fusions result
in BMC encasement we chose to use a protease protection assay
that was previously reported by Sargent et al. (2013). In this assay
we used GFP as a marker to demonstrate that the protein is pro-
tected within the confines of the BMC. To this end plasmids were
constructed containing GFP fused to an N-terminal D18 or P18 tag
as well as a C-terminal SsrA proteolysis tag (AANDENYALAA*). The
C-terminal SsrA tag targets proteins for degradation by the E. coli
proteases ClpAP and ClpXP (Farrell et al., 2005). E. coli was trans-
formed with plasmids encoding the protein fusions with and
without shell proteins and the resulting strains were cultured for
24 h. Samples were taken and analysed by SDS-PAGE and subject
to western blotting using an anti-GFP primary antibody. The
results show that the co-expression of GFP-SsrA fused to targeting
peptides, when produced with shell proteins, have the highest
levels of GFP (Fig. 4; lanes 7þ8). In the absence of a targeting
peptide GFP is effectively degraded as observed by the presence of
only a faint band present (Fig. 4; lane 6). In the absence of shell
proteins all GFP fusion proteins are present to a much lesser extent
than fusion proteins in the presence of microcompartments. These
results are consistent with the theory that BMCs provide protec-
tion for internalised proteins.
Fig. 3. Statistical analysis showing the percentage of cells expressing tagged/
untagged proteins containing inclusion bodies. For each strain 100 cells were
observed by TEM.
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3.4. Construction of 1,2-propanediol producing strains
The untagged genes for the four pathway enzymes were cloned
consecutively using the Link and Lock procedure to give pML5
(containing gldA, mgsA, dhaK, fucO) whereas the tagged versions
were cloned in a similar fashion to give pML6 (containing P18-
gldA, D18-mgsA, P18-dhaK, D18-fucO). Both plasmids were trans-
formed into E. coli strain BL21*(DE3). The strains were further
engineered to co-express the 1,2-propanediol production plasmids
by transforming themwith a compatible plasmid housing the shell
protein genes (pLysS-pduABJKNU). Additionally, a control strain
containing empty versions of pET14b and pLysS was generated as
was a strain transformed with pET14b and pLysS-pduABJKNU. All
strains were compared for the production of 1,2-propanediol.
The strains were grown in 100 mL cultures at 28 °C and sam-
ples were collected at 0, 6, 12, 24, 48, 72 and 96 h. The resulting
growth curves (Supplementary Fig. S7) show that strains encoding
proteins with targeting peptides (either in the presence of absence
of shell proteins) grow slower and reach a lower final optical
density in comparison to strains expressing un-tagged proteins
and control strains. When analysing the protein profiles of whole
cell samples at the various time points we found marginally higher
production levels of some tagged proteins compared to the non-
tagged proteins (Supplementary Fig. S8 c, d, e and f). Increased
protein production and protein aggregation may lead to cells
undergoing senescence mediated by asymmetric segregation of
protein aggregates (Baig et al., 2014), which potentially explains
why these strains did not grow as well as strains producing the
same proteins without targeting peptides. Whole cell samples of
strains housing the shell protein construct (pLysS-pduABJKNU)
showed the protein profile expected for the shell components as
observed by SDS-PAGE (Supplementary Fig. S8 b, e and f). The
strain encoding only empty microcompartments appears to have a
slightly higher production of shell proteins as evidenced by
increased band intensity on the SDS-PAGE gels (Supplementary
Fig. S8 b).
3.5. In vivo 1,2-propanediol production is elevated in strains pro-
ducing enzymes with targeting sequences
The 1,2-propanediol content in the growth media of the various
strains was quantified by GC–MS. Samples were collected at 0, 6,
12, 24, 48, 72 and 96 h and, following centrifugation, the resultant
supernatant was analysed by GC–MS as described in materials and
methods. The measured 1,2-propanediol content, as shown in
Fig. 5, is expressed for a cell density of OD600¼1 (for the non-
adjusted data see Supplementary Fig. S9). Strains encoding the un-
tagged enzymes, His-GldA, His-DhaK, His-MgsA and His-FucO,
whether in the presence of absence of BMCs, were found to pro-
duce low levels of 1,2-propanediol despite growing well and
reaching the highest cell densities after 96 h.
Intriguingly, the highest levels of 1,2-propanediol were detec-
ted in the growth media of strains producing enzymes containing
the fused targeting peptides. Thus strains producing P18-GldA,
P18-DhaK, D18-MgsA and D18-FucO, whether in the presence or
absence of BMCs, grew to a lower cell density than the strains
harbouring un-tagged proteins, and despite the negative effect the
targeting peptide has on the specific activities of the individual
enzymes they produced significantly more 1,2-propanediol (Fig. 2,
Fig. 5, and Supplementary Fig. S9) than the strains lacking the
targeting peptides. The highest final yield of 1,2-propanediol was
11.56 mM/OD600 unit, which was observed when the shell proteins
were not present. No 1,2-propanediol was detected in control
stains (wild type E. coli and a strain producing shell proteins only).
3.6. TEM analysis of 1,2-propanediol producing strains
The higher product yield exhibited by the strain producing
tagged enzymes in the absence of shell proteins was unexpected.
To investigate if aggregation of the enzymes was causing this
effect electron microscopy and immuno-gold labelling were used
to visualise the subcellular organisation and location of the
recombinant proteins in the various strains after the cells had been
thin sectioned. To achieve this the thin sections of the strains were
labelled with anti-histidine primary antibody, which is designed to
bind to the hexa-histidine tag on the N-terminus of the various
proteins. A secondary antibody conjugated to 10 nm gold particles
was used to bind to the primary antibody, thereby revealing the
intracellular location of 1,2-propanediol producing enzymes.
Control stains housing either empty vectors (pET14bþpLysS) or
producing only the BMCs (pLysS-pduABJKNU) showed a small
amount of antibody binding around the membranes of the cells
(Fig. 6A and B); this is likely due to nonspecific binding. Aggre-
gates, or large protein inclusions, are visible in approximately 100%
Fig. 4. Protease protection assay of GFP fused to a C-terminal proteolysis tag and an
N-terminal targeting peptide in the presence and absence of BMCs. Total lysates
were analysed by SDS-PAGE and subsequently western blotted with an anti-GFP
primary antibody. Cell densities were normalised to an OD600¼2.5 for loading of
samples. The faint bands seen in lanes 2-6 may, in part, be a result of unspecific
binding, as a faint band is also seen in lane 1 (shell proteins only, no GFP).
Fig. 5. In vivo 1,2-propanediol production. The graph shows the 1,2-propanediol
content (normalised to OD600¼1) over 96 h in the growth medium of strains that
lack shell proteins and 1,2-propanediol producing enzymes (control strain) (●),
shell proteins only (control strain) (◯), untagged 1,2-propanediol producing
enzymes (▼), 1,2-propanediol producing enzymes tagged with targeting peptides
(△),untagged 1,2-propanediol producing enzymes and shell proteins (■),1,2-pro-
panediol producing enzymes tagged with targeting peptides and shell proteins (⎕).
Data points represent an average of three independent experiments; standard
deviations are represented by error bars.
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Fig. 6. Thin sections of E. coli strains labelled with an anti-his antibody and then with a secondary antibody conjugated to 10 nm gold particles viewed under TEM (A) strain
that lacks shell proteins and 1,2-propanediol producing enzymes (control strain) (B) strain producing shell proteins only (control strain) (C) 1,2-propanediol producing
enzymes tagged with targeting peptides (D) 1,2-propanediol producing enzymes tagged with targeting peptides and shell proteins (E) untagged 1,2-propanediol producing
enzymes (F) untagged 1,2-propanediol producing enzymes and shell proteins. White pointers indicate gold particles.
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of observed cells expressing the P18/D18-tagged proteins,
regardless of whether BMCs are present. It is in these aggregate
areas that the vast majority of antibody binding occurs (Fig. 6C and
D). Such protein inclusions are not seen in cells expressing un-
tagged enzymes (Fig. 6E and F), suggesting that it is the presence
of the targeting peptides that facilitates the aggregation of pro-
teins. In strains producing shell proteins, BMCs can be clearly seen
grouped together within the cytoplasm of the cells when viewed
by TEM (Supplementary Fig. S10). In the micrographs shown here
the BMCs have low contrast because of the nature of sample
preparation for immunolabelling (Fig. 6B, D and F). Only very few
gold particles can be seen in the strain producing tagged enzymes
and microcompartments in the region of the BMCs.
The combined data from both the 1,2-propanediol production
studies and the TEM analysis of thin sections of bacteria from the
various strains all suggest that maximum 1,2-propanediol pro-
duction is due to the formation of a large active enzyme-inclusion
body within the cell. The presence of the D18 and P18 fusion tags
on the four enzymes (GldA, DhaK, MgsA and FucO) appears to
result in the formation of a large protein aggregate when the four-
tagged enzymes are co-produced. This large aggregate forms both
in the presence and absence of BMCs.
4. Conclusions
Previously, we had shown that targeting of a two-enzyme
heterologous pathway for ethanol production to engineered
BMCs significantly increased the in vivo product yield in E. coli.
Here, we have chosen to expand and apply our earlier findings to a
pathway with industrial significance by engineering recombinant
BMCs to house a four-enzyme pathway for the production of 1,2-
propanediol from glycerol (GldA, DhaK, MgsA and FucO) in E. coli.
Glycerol is a cheap and widely available source for the production
of 1,2-propanediol, a valuable commodity chemical that is cur-
rently obtained from fossil fuel derivatives.
The first stage of the investigation into 1,2-propanediol synth-
esis in BMCs was to determine the effect of the BMC-targeting
peptides, D18 and P18, on the pathway enzymes. The in vitro data
presented in this study has revealed that the fusion of targeting
peptides to the individual pathway enzymes has a variable effect
on the properties of each protein. Differences can be seen in the
levels of the protein, stability and in enzymatic activity. Three of
the four tagged enzymes (GldA, MgsA and FucO) had lowered
specific activities, caused by the addition of the 18 amino acid
targeting sequences onto the N-terminus of the proteins. More-
over, the presence of the different peptide fusions, D18 and P18,
had altered effects on the activity of the same enzyme. The solu-
bility of each protein was also affected by the attachment of the
peptide fusion, with GldA forming large inclusion bodies in the
majority of cells observed by TEM when fused with a targeting
peptide compared to un-tagged GldA.
To demonstrate that the D18 or P18 peptide was able to loca-
lise, individually, the 1,2-propanediol enzymes to the BMC, the
four tagged enzymes were separately co-produced with the
‘empty’ Pdu BMC. In each case the tagged enzyme was found to co-
purify with the BMC, suggesting that that the enzyme had been
correctly targeted to the BMC. This in itself does not prove that the
tagged enzyme has been encased within the recombinant BMC,
merely that it associates with the BMC. Evidence that the D18 or
P18 tagged proteins are internalised was provided by a protease
protection assay using GFP as the cargo for the BMC. The presence
of either the P18 or D18 peptide on the GFP protected the GFP from
proteolysis but only when the tagged protein was co-produced
with BMCs.
In an attempt to target the whole 1,2-propanediol pathway to a
BMC, the genes encoding the most active of the individually tag-
ged enzymes (P18-GldA, P18-DhaK, D18-MgsA and D18-FucO)
were cloned consecutively on a single plasmid so that the whole
pathway would be targeted to empty BMCs. In vivo analysis of 1,2-
propanediol production of the strain showed that fusion of tar-
geting peptides to all of the proteins involved in the synthesis of
1,2-propanediol resulted in an increase in product formation.
Rather unexpectedly, the presence of the microcompartment
shell was not required for the increased product formation. In fact,
the strain generating the most 1,2-propanediol produced tagged
1,2-propanediol pathway enzymes, but no shell proteins. This
strain showed an increase in product formation of 245% OD-
adjusted and 157% not OD-adjusted in comparison to the strain
producing un-tagged enzymes; despite the lower in vitro activity
of the individual tagged proteins compared to the un-tagged
proteins. TEM analysis showed that co-production of all four
proteins resulted in protein aggregation and deposition at the
poles of nearly all cells and it is this aggregation that appears to
provide a significant benefit to the efficiency of the pathway.
Aggregation of our proteins of interest may be due to coiled coil
interactions facilitated by the targeting peptides as previously
shown for the P18 sequence, which appears to form a coiled coil
dimer in solution (Lawrence et al., 2014). Pathway productivity
could be further enhanced by introducing a cofactor-recycling
enzyme; this has been previously implemented to enhance a
related pathway for dihydroxyacetone production (Zhou et al.,
2013). Through the use of a tightly regulated fermentation system
it would reasonably be expected that pathway productivity could
be further enhanced.
Hence, it could be assumed that the increased product yield is a
result of concentrating enzymes into aggregates. As such this
scaffold might result in increased channelling of substrates and
products between proteins due to proximity effects. The formation
of this aggregate may be a mimic of what happens in nature
during BMC formation. For instance, in the case of the carboxy-
some, the cargo enzymes initially condense and are then encased
by the shell of the BMC. The reason inclusion bodies are observed
in this study even when shell proteins are co-produced is that the
expression of the pathway genes is under the control of a strong
T7 promoter which leads to disproportional ratios of cargo enzyme
to shell proteins. Surplus protein, which is not encapsulated, is
aggregated. In wild type operons gene expression and thus protein
levels are controlled by regulatory elements, promoters and ribo-
some binding sites of various strengths.
In summary, the work described in this report demonstrates
that the presence of short targeting peptides can not only convert
individual fusion proteins but also whole pathways into active
aggregates that allow for increased product yield in vivo. The
aggregations of multiple enzymes allows for increased localised
concentrations of enzymes and intermediates within the cell
resulting in a higher product yield. In essence, these metabolic
aggregates that are formed by the attachment of BMC-targeting
peptides represent BMCs without shells. Hence, engineered pro-
tein aggregation for instance through the design of coiled coil
interactions may hold an important role in the future of metabolic
engineering for the production of commodity products. Active
protein aggregates may have prolonged extracellular activity and
therefore be more robust than BMCs. The use of BMCs for pathway
localisation still remains desirable in the field of metabolic engi-
neering. Pathways involved in the microbial production of biofuels
often contain toxic intermediates and therefore compartmentali-
sation may reduce the negative effect of these toxic intermediates
on the cell and thus increase fitness and productivity. Here we
have shown that the formation of recombinant BMCs requires the
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coordinated production of protein cargo in a controlled manner for
the construction of bioreactors of predictable functionality.
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Supplementary Table 1: Strains used in this study 
Strain Genotype Source 
JM109 endA1, recA1, gyrA96, thi, hsdR17 (rk–, 
mk+), relA1, supE44, Δ(lac-proAB), [F′, 
traD36, proAB, laqIqZΔM15] 
Promega 
BL21 (DE3) F– ompT hsdSB (rB– mB–) gal dcm (DE3) Novagen 
BL21 (DE3) pLysS F- ompT hsdSB(rB- mB-) gal dcm (DE3) 
pLysS (CamR) 
Novagen 
Supplementary Table 2: Plasmids used in this study 
Plasmid name Description Source 
pET14b Overexpression vector containing N-
terminal hexahistidine-tag, modified to 
include an SpeI site 5’ of BamHI 
Novagen 
pET14b-D18 Overexpression vector containing an N-
terminal D18 targeting tag followed by a 
short amino acid linker (AMGSS) then a 
hexahistidine-tag 
This study 
pET14b-P18 Overexpression vector containing an N-
terminal P18 targeting tag followed by a 
short amino acid linker (PMGSS) then a 
hexahistidine-tag 
This study 
pLysS Basal expression suppressor  Novagen 
pLysS-2 Basal expression suppressor containing 
the T7 promoter-MCS-T7 terminator 
cassette from pET14b 




pLysS-2 containing genes required for the 
formation of empty BMCs 
Parsons et al., 
2010 
pET14b-gldA PCR product of gldA ligated into NdeI/SpeI 
sites of pET14b 
This study 
pET14b-dhaK PCR product of dhaK ligated into 
NdeI/SpeI sites of pET14b 
This study 
pET14b-mgsA PCR product of mgsA ligated into 





pET14b-fucO PCR product of fucO ligated into 
NdeI/SpeI sites of pET14b 
This study 
pET14b-GFP-SsrA PCR product of gfp-ssrA ligated into 
NdeI/SpeI sites of pET14b 
This study 
pET14b-D18-gldA NdeI/SpeI fragment of pET14b-gldA 
ligated into NdeI/SpeI sites of pET14b-D18 
This study 
pET14b-D18-dhaK NdeI/SpeI fragment of pET14b-dhaK 




NdeI/SpeI fragment of pET14b-mgsA 
ligated into NdeI/SpeI sites of pET14b-D18 
This study 
pET14b-D18-fucO NdeI/SpeI fragment of pET14b-fucO 




NdeI/SpeI fragment of pET14b-GFP-SsrA 
ligated into NdeI/SpeI sites of pET14b-D18 
This study 
pET14b-P18-gldA NdeI/SpeI fragment of pET14b-gldA 
ligated into NdeI/SpeI sites of pET14b-P18 
This study 
pET14b-P18-dhaK NdeI/SpeI fragment of pET14b-dhaK 
ligated into NdeI/SpeI sites of pET14b-P18 
This study 
pET14b-P18-mgsA NdeI/SpeI fragment of pET14b-mgsA 
ligated into NdeI/SpeI sites of pET14b-P18 
This study 
pET14b-P18-fucO NdeI/SpeI fragment of pET14b-fucO 




NdeI/SpeI fragment of pET14b-GFP-SsrA 
ligated into NdeI/SpeI sites of pET14b-P18 
This study 
pML-1 XbaI/EcoRI fragment from pET14b-fucO 
ligated into XbaI/EcoRI sites of pET14b-
gldA 
This study 
pML-2 XbaI/EcoRI fragment from pET14b-D18-
fucO ligated into SpeI/EcoRI sites of 
pET14b-P18-gldA 
This study 
pML-3 XbaI/HindIII fragment from pET14b-mgsA 
ligated into SpeI/HindIII sites of pET14b-
dhaK 
This study 
pML-4 XbaI/HindIII fragment from pET14b-D18-






pML-5 XbaI/ClaI fragment from pML-3 ligated into 
SpeI/ClaI sites of pML-1 
This study 
pML-6 XbaI/ClaI fragment from pML-4 ligated into 





Supplementary Table 3:  Oligonucleotides used in this study, restriction sites are 
underlined 



























Supplementary Figure S1: SDS-PAGE of GldA purified by IMAC (a) GldA (b) D18-
GldA (c) P18-GldA; In comparison to a molecular weight marker. Lane 1 – lysate (2 
µl), lane 2 – supernatant after centrifugation (2 µl), lane 3 – pellet after centrifugation 
(10 µl), lane 4 – supernatant flow through (8 µl), lane 5 – binding buffer flow through 
(5 mM imidazole) (10 µl), lane 6 – wash buffer 1 flow through (50 mM imidazole) (10 
µl), lane 7 – wash buffer 2 flow through (100 mM imidazole) (10 µl), lanes 8– 11 – 
elution fractions 4-7 (400 mM imidazole) (5 µl), lane 12 – sample after buffer 





Supplementary Figure S2: SDS-PAGE of DhaK purified by IMAC (a) DhaK (b) D18-
DhaK (c) P18-DhaK; In comparison to a molecular weight marker. Lane 1 – lysate (3 
µl), lane 2 – supernatant after centrifugation (3 µl), lane 3 – pellet after centrifugation 
(10 µl), lane 4 – supernatant flow through (10 µl), lane 5 – binding buffer flow through 
(5 mM imidazole) (10 µl), lane 6 – wash buffer 1 flow through (50 mM imidazole) (10 
µl), lane 7 – wash buffer 2 flow through (100 mM imidazole) (10 µl), lanes 8– 11 – 
elution fractions 2-5 (400 mM imidazole) (3 µl), lane 12 – sample after buffer 






Supplementary Figure S3: SDS-PAGE of MgsA purified by IMAC. (a) MgsA (b) 
D18-MgsA (c) P18-MgsA; In comparison to a molecular weight marker. Lane 1 – 
lysate (2 µl), lane 2 – supernatant after centrifugation (2 µl), lane 3 – pellet after 
centrifugation (10 µl), lane 4 – supernatant flow through (3 µl), lane 5 – binding buffer 
flow through (5 mM imidazole) (10 µl), lane 6 – wash buffer 1 flow through (50 mM 
imidazole) (10 µl), lane 7 – wash buffer 2 flow through (50 mM imidazole) (10 µl), 
lanes 8– 11 – elution fractions 2-5 (400 mM imidazole) (2 µl), lane 12 – sample after 






Supplementary Figure S4: SDS-PAGE of FucO purified by IMAC (a) FucO (b) D18-
FucO (c) P18-FucO; In comparison to a molecular weight marker. Lane 1 – lysate (4 
µl), lane 2 – supernatant after centrifugation (4 µl), lane 3 – pellet after centrifugation 
(10 µl), lane 4 – supernatant flow through (10 µl), lane 5 – binding buffer flow through 
(5 mM imidazole) (10 µl), lane 6 – wash buffer 1 flow through (50 mM imidazole) (10 
µl), lane 7 – wash buffer 2 flow through (100 mM imidazole) (10 µl), lanes 8– 11 – 
elution fractions 3-6 (400 mM imidazole) (2 µl), lane 12 – sample after buffer 





Supplementary Figure S5: TEM analysis of strains expressing (A) GldA (B) P18- 
GldA (C) DhaK (D) P18-DhaK (E) MgsA (F) D18-MgsA (G) FucO (H) D18-FucO. 







Supplementary Figure S6 SDS-PAGE analysis of purified BMCs co-produced with 








Supplementary Figure S7: Growth curves of strains producing 1,2-propanediol and 
control strains shown as OD600 against time (hours). E. coli strain that lacks shell 
proteins and 1,2-propanediol producing enzymes (control strain) (), Shell proteins 
only (control strain) (), untagged 1,2-propanediol producing enzymes (q), 1,2-
propanediol producing enzymes tagged with targeting peptides (r), untagged 1,2-
propanediol producing enzymes and shell proteins (¢),1,2-propanediol producing 
enzymes tagged with targeting peptides and shell proteins (£). Data points represent 
an average of three independent experiments; standard deviations are represented 







Supplementary Figure S8: SDS-PAGE and western blot analysis of final whole cell 
samples of (A) strain that lacks shell proteins and 1,2-propanediol producing 
enzymes (control strain) (B) shell proteins only (PduABB’JKNU) (control strain) (C) 
P18/D18-tagged-DhaK, MgsA, GldA and FucO  (D) P18/D18-tagged-DhaK, MgsA, 
GldA and FucO + PduABB’JKNU (E) untagged-DhaK, MgsA, GldA and FucO (F) 







Supplementary Figure S9 In vivo 1,2-propanediol production. The graph shows the 
1,2-propanediol content over 96 h in the growth medium in of strains that lack shell 
proteins and 1,2-propanediol producing enzymes (control) (), shell proteins only 
(control strain) (), untagged 1,2-propanediol producing enzymes (q), 1,2-
propanediol producing enzymes tagged with targeting peptides (r),untagged 1,2-
propanediol producing enzymes and shell proteins (¢),1,2-propanediol producing 
enzymes tagged with targeting peptides and shell proteins (£). Data points represent 
an average of three independent experiments; standard deviations are represented 







Supplementary Figure S10: TEM micrograph showing thin section of E. coli strain 























Embedding of strains for TEM analysis 
 
50 ml of LB was inoculated with one colony and grown at 37 °C with shaking to an 
OD600 of ~ 0.4, cells were harvested by centrifugation at 3000 x g for 10 minutes. 
The cell pellet was resuspended in 2 ml 2.5% Glutaraldehyde in 100 mM sodium 
cacodylate buffer pH 7.2 (CAB) and fixed for 2 hours with gentle rotating (20 rpm). 
Cells were pelleted by centrifugation at 6000 x g for 2 minutes and were washed 
twice for 10 minutes with 100 mM CAB. Cells were post-fixed with 1% osmium 
tetroxide in 100 mM CAB for 2 hours and subsequently washed twice with dH2O. 
Cells were dehydrated by incubation in an ethanol gradient, 50% EtOH for 10 
minutes, 70% EtOH overnight, 90% EtOH for 10 minutes followed by three 10 minute 
washes in 100% dry EtOH. Cells were then washed twice with propylene oxide for 15 
minutes. Cell pellets were embedded by resuspension in 1 ml of a 1:1 mix of 
propylene oxide and Agar LV Resin and incubated for 30 minutes with rotation. Cell 
pellets were infiltrated twice in 100% Agar LV resin. The cell pellet was re-suspended 
in fresh resin and transferred to a 1ml Beem embedding capsule, centrifuged for 5 
minutes at 3000 x g to concentrate the cells to the tip of the mould and incubated for 
20 hours at 60 °C to polymerise.  
 
Sectioning and visualisation of samples  
 
Samples were ultra-thin sectioned on a RMC MT-XL ultra-microtome with a diamond 
knife (diatome 45°) sections (60 – 70 nm) were collected on un-coated 300 mesh 
copper grids. Grids were stained by incubation in 4.5% uranyl acetate in 1% acetic 
acid solution for 45 minutes followed by washing in a stream of dH2O. Grids were 
then stained with Reynolds lead citrate for 7 minutes followed by washing in a stream 
of dH2O 
 
Electron microscopy was performed using a JEOL-1230 transmission electron 
microscope equipped with a Gatan multiscan digital camera operated at an 
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I
n industrial biotechnology and synthetic biology there is a grow-
ing need to generate internal supramolecular scaffolds in bac-
teria en route to delivering so-called cell factories1. To this end, 
researchers have investigated protein-based linkers2, lipids3 and 
nucleic acids4,5 as modulators to attain high-level biomolecular 
organization. However, none of these approaches have delivered a 
uniform matrix throughout the bacterial cytoplasm. The advantage 
of such scaffolding systems is that they can be used to direct and 
align biosynthetic pathway enzymes to orchestrate greater produc-
tion of commodity and specialty chemicals, especially in pathways 
that proceed through unstable or toxic intermediates6,7. This is 
because the close proximity of enzymes on a scaffold allows greater 
channeling of intermediates through improved flux, stabilization of 
intermediates and protection from other reactions8,9.
A number of natural scaffolds are found in bacterial cells. For 
instance, bacterial microcompartments (BMCs) are organelles with 
an outer semipermeable scaffold in the form of a protein shell, which 
encases a specific metabolic pathway10–12. BMCs have a diameter of 
approximately 150 nm and possess high concentrations of inter-
nalized enzymes. This is most apparent in carboxysomes, which 
are anabolic BMCs wherein the high concentrations of carbonic 
anhydrase and ribulose-1,2-bisphosphate carboxylase/oxygenase 
(RuBisCO) ensure enhanced carbon fixation13,14. In catabolic BMCs, 
such as the metabolosome associated with propanediol utilization 
(the so-called Pdu system), internalized enzymes necessitate that 
propionaldehyde be rapidly transformed into either an alcohol or 
a CoA thioester, thereby protecting the cell from the potentially 
toxic aldehyde intermediate15–17. In all cases, the enzymes are tar-
geted to the interior of the BMCs by small encapsulation peptides, 
which interact with a component of the outer-shell scaffold18–21. 
Modeling studies indicate that BMCs enhance flux through inter-
mediate sequestration22. Recently, a detailed structure of a recombi-
nant BMC shell has been reported showing the precise orientation 
of the different shell proteins that tile together to form the outer 
casing, providing molecular detail on how the shell proteins scaffold 
together to act as a semipermeable membrane23.
Apart from BMCs, the other major scaffold within prokaryotic 
cells is the cytoskeleton24, which is generally distributed around 
the inner membrane. This filamentous structure, which includes 
proteins such as FtsZ, MreB, ParM and MinD25,26, has roles in cell 
division, cell morphology and structural polarity. However, the 
essential nature of these proteins precludes them from being devel-
oped as major cellular matrices. For these reasons, we sought to 
construct a simple and modular bacterial cytoskeleton, which we 
call a cytoscaffold, using components that we understand and can 
manipulate predictably.
Previously, we have shown that a single shell protein from the 
Citrobacter freundii Pdu BMC, with a minor modification to its C 
terminus to improve solubility (PduA*), forms filaments in E. coli27. 
PduA itself hexamerizes to form a tile that assembles to make the 
facets of the BMC casing28,29. However, when overproduced recom-
binantly in E. coli, PduA* forms hollow filaments approximately 
20 nm in diameter that span the length of the cell30. Moreover, 
these structures often interfere with septation during cell division. 
Nonetheless, we reasoned that PduA*-based filamentous structures 
may present tractable scaffolds for tethering other proteins.
Here, we describe a three-component system comprising PduA* 
and two complementary de novo–designed coiled-coil peptides31, 
which form an interactive intracellular filamentous arrangement that 
gives the appearance of a matrix permeating the entire E. coli cyto-
plasm (Supplementary Results, Supplementary Fig. 1). We show 
that other proteins can be specifically targeted to these cytoscaffolds. 
Building on this, we demonstrate that tethering metabolic enzymes 
for ethanol production to the PduA* scaffold increases their effec-
tive local and relative concentrations and results in improved etha-
nol production. Finally, we show that the scaffold can be directed 
1Industrial Biotechnology Centre, School of Biosciences, University of Kent, Canterbury, UK. 2School of Biochemistry, University of Bristol, Medical 
Sciences Building, University Walk, Bristol, UK. 3Wolfson Bioimaging Facility, Medical Sciences Building, University Walk, Bristol, UK. 4School of Chemistry, 
University of Bristol, Cantock’s Close, Bristol, UK. 5Department of Biochemical Engineering, University College London, Bernard Katz Building, Gordon 
Street, London, UK. 6BrisSynBio, Life Sciences Building, Tyndall Avenue, Bristol, UK. *e-mail: M.J.Warren@kent.ac.uk or D.N.Woolfson@bristol.ac.uk
Engineered synthetic scaffolds for organizing 
proteins within the bacterial cytoplasm
Matthew J Lee1, Judith Mantell2,3, Lorna Hodgson2, Dominic Alibhai3, Jordan M Fletcher4,  
Ian R Brown1, Stefanie Frank5, Wei-Feng Xue1   , Paul Verkade2,3,6, Derek N Woolfson2,4,6*  
& Martin J Warren1   *
We have developed a system for producing a supramolecular scaffold that permeates the entire Escherichia coli cytoplasm. 
This cytoscaffold is constructed from a three-component system comprising a bacterial microcompartment shell protein and 
two complementary de novo coiled-coil peptides. We show that other proteins can be targeted to this intracellular filamen-
tous arrangement. Specifically, the enzymes pyruvate decarboxylase and alcohol dehydrogenase have been directed to the fila-
ments, leading to enhanced ethanol production in these engineered bacterial cells compared to those that do not produce the 
scaffold. This is consistent with improved metabolic efficiency through enzyme colocation. Finally, the shell-protein scaffold 
can be directed to the inner membrane of the cell, demonstrating how synthetic cellular organization can be coupled with spatial 
optimization through in-cell protein design. The cytoscaffold has potential in the development of next-generation cell factories, 
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to the inner membrane of the cell, further illustrating its modular-
ity, flexibility, and utility, and demonstrating how synthetic cellular 
organization can be coupled with spatial optimization.
RESULTS
Construction of a filamentous scaffold
Initially, we tested whether different proteins could be recruited to 
PduA* filaments in vivo in an analogous way to how encapsulation 
peptides are thought to work in natural BMCs (see above). Attempts 
to use the natural encapsulation peptides themselves were not very 
successful, mainly owing to aggregation within the cell32. Therefore, 
we turned to a better-characterized de novo–designed heterodimeric 
coiled-coil system, CC-Di-AB31, which has been used successfully in 
the construction of self-assembling peptide cages33. The heterodimer 
comprises two peptides (acidic (A) and basic (B)) that do not self-
associate, but interact specifically and tightly when mixed. The con-
cept was to fuse either CC-Di-A or CC-Di-B to PduA* and then test 
whether a reporter protein with the cognate peptide can be targeted 
to the filaments. Plasmids encoding fusion proteins of the following 
type were made: CC-Di-A/B–Gly/Ser linker–HexaHisTag–PduA*, 
referred to as CC-Di-A–PduA* and CC-Di-B–PduA*. A control 
plasmid harboring the fusion without the CC-Di-A/B module, 
i.e., containing only the Gly/Ser linker–HexaHisTag (C–PduA*), 
was also made. Plasmids were transformed individually into E. coli 
cells, and the resulting strains were grown, induced and analyzed by 
transmission electron microscopy (TEM) after fixation, embedding, 
thin sectioning and staining.
Strains expressing PduA* alone generated parallel filaments 
spanning the length of the cell (Fig. 1a) and appear to interfere 
with septation (Supplementary Fig. 2). Unexpectedly, the strains 
producing the control C–PduA* and the CC-Di-A–PduA* did 
not form any filamentous structures (Fig. 1b and Supplementary 
Fig. 3). C–PduA* expression led to deposits of material at the 
poles of the cell, suggesting that the Gly/Ser linker and/or the 
hexahistidine tag alone affects solubility of the fusion protein. 
This was not seen with CC-Di-A–PduA*, but it is not clear why 
filaments do not form with this construct. In both cases, west-
ern blot analysis revealed only low levels of CC-Di-A–PduA* and 
C–PduA* relative to untagged PduA*, suggesting potential cyto-
toxicity of these proteins (Supplementary Fig. 4). In contrast, 
large amounts of CC-Di-B–PduA* were detected (Supplementary 
Fig. 4), and this led to numerous filaments throughout the cyto-
plasm (Fig. 1c and Supplementary Fig. 5). These filaments had a 
diameter of 23.6  2.78 nm (n = 100), similar to those of untagged 
PduA* filaments30, but the former were considerably shorter 
(Fig. 1d,e). Consequently, CC-Di-B–PduA* filaments were not 
aligned within cells, and they did not appear to disrupt cells. It is 
not clear why the CC-Di-B–PduA* filaments are shortened, but 
it is possible that the highly charged CC-Di-B peptide may limit 
filament growth in some way.
Characterization of the cytoscaffold
To probe the spatial localization and organization of the shorter 
CC-Di-B–PduA* filaments, thicker thin sections (250 nm) were cut 
and prepared for TEM tomography. Analysis of the resulting tomo-
gram confirmed the presence of the shorter filaments throughout 
the cytoplasm, except in a central region that is largely occupied 
by genomic DNA (Fig. 1f). Using methods developed to track 
microtubule assemblies in cells34, we rendered these structures and 
visualized them in three dimensions (Fig. 1f and Supplementary 
Videos 1 and 2). From this, it was clear that the filaments were 
not aligned, but arrayed with multiple orientations, resulting in 
the appearance of an internal matrix. Analysis of these filaments 
revealed an average length of 161.2  102.4 nm (n = 739); though 
because of the limitation of a 250 nm thin section, the true length is 
likely longer than this (Fig. 1e).
To test the robustness of the CC-Di-B–PduA* filaments, and to 
interrogate their structure in more detail, we purified the filaments 
from cells using protocols developed for BMC isolation21. Cells were 
lysed, and the filaments were purified by combining centrifugation 
and differential salt precipitation (Supplementary Fig. 6). Purified 
filaments were analyzed by TEM and atomic force microscopy 
(AFM). Both confirmed intact filaments, and these approaches 
provided the opportunity to gain greater insight into the molecu-
lar organization of these structures (Supplementary Fig. 7). These 
ex vivo filaments tended to cluster together on the TEM grids and 
AFM substrates. This clustering was also seen, though to a lesser 
extent, in some thin sections of whole cells visualized by TEM.
Targeting to and functionalization of the cytoscaffold
Next, we tested whether the CC-Di-B peptides of the CC-Di-B–PduA* 
filaments were accessible for targeting by other proteins labeled with 
CC-Di-A using the fluorescent protein Citrine. To do this, we made 
CC-Di-A–Citrine and C–Citrine constructs similar in design to the 
fusion proteins described above. By cloning these constructs in com-
patible plasmids, we could either transform these alone or co-trans-

































Figure 1 | Transmission electron micrographs and analysis of PduA*-
based constructs and filaments in E. coli. (a) Untagged PduA* filaments. 
(b,c) CC-Di-A–PduA* (b) and CC-Di-B–PduA* (c) filaments. Scale bars 
in a–c, 200 nm. (d) Histogram showing the diameter of CC-Di-B-PduA* 
filaments (n = 100 measurements). (e) Histogram showing lengths of 
CC-Di-B-PduA* filaments based on a 250 nm tomogram rendering shown 
in f (n = 739 filaments). (f) 3D rendering of CC-Di-B–PduA* filaments 
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On their own, CC-Di-A–Citrine and C–Citrine each produced 
uniform fluorescence throughout the cells, consistent with soluble, 
cytoplasmic proteins (Supplementary Fig. 8). Similarly, when co-
expressed with CC-Di-B–PduA*, the C–Citrine control produced 
fluorescence that was distributed throughout the cell. In contrast, 
co-expression of CC-Di-A–Citrine and CC-Di-B–PduA* produced 
more punctate fluorescence, as well as reduced fluorescence around 
the genomic DNA (Fig. 2a). This is consistent with CC-Di-A–Citrine 
being localized to the filamentous scaffold. Correlative light electron 
microscopy (CLEM)35,36 of high-pressure frozen cells co-expressing 
CC-Di-A–GFP and CC-Di-B–PduA* confirmed the localization of 
fluorescence to the intracellular filamentous network (Fig. 2b–e). 
Control strains expressing the CC-Di-B–PduA* filaments with 
untagged GFP showed only a cytoplasmic signal (Supplementary 
Fig. 9). Expression of CC-Di-B–Citrine with or without CC-Di-B–
PduA* resulted in punctate fluorescence, suggesting self-association 
of the CC-Di-B peptide (Supplementary Fig. 8).
To demonstrate that multiple cargo proteins can be directed to 
the cytoscaffold, we co-produced CC-Di-A–Citrine and a CC-Di-
A–mCherry fusion in cells with CC-Di-B–PduA* filaments. This 
gave patterns similar to those observed with CC-Di-A–Citrine plus 
CC-Di-B–PduA*, and the mCherry signals colocalized with the 
Citrine signals (Fig. 2f–h).
Although the results clearly demonstrate that fluorescent 
proteins can be localized to the PduA* filaments through the 
use of the coiled-coil interaction, we also wanted to investigate 
whether enzymes could be pegged onto the CC-Di-B-PduA*  
filaments in a similar fashion. To explore this, we tagged both pyru-
vate decarboxylase (Pdc) and alcohol dehydrogenase (Adh) with 
the CC-Di-A peptide and co-expressed these with and without the 
CC-Di-B–PduA* filaments. Intriguingly, strains expressing Pdc 
and Adh grew to a substantially higher optical density at 600 nm 
(OD600) in comparison to both control strains (Supplementary 
Fig. 10a). GC–MS analysis of the growth medium revealed that 
the introduction of the CC-Di-B–PduA* filamentous network 
increased ethanol production by 221% per OD unit (t = 120 h) 
in comparison to a strain expressing Pdc and Adh, but not the 
cytoscaffold (Fig. 3 and Supplementary Fig. 10b). Western 
blot analysis showed that this increase in ethanol production was 
not due to increased protein expression: indeed, the levels of Pdc 
and Adh were actually reduced by 48  13.3% and 26  5.5%, 
respectively, in the strain expressing CC-Di-A-tagged enzymes in 
the presence of the CC-Di-B–PduA* filaments (Supplementary 
Fig. 11). The presence of filaments in these strains was con-
firmed by TEM analysis (Supplementary Fig. 12). These experi-
ments provide strong evidence that the localization of enzymes 










Figure 2 | Localization of fluorescent proteins to a bacterial cytoscaffold. 
(a) Co-expression of CC-Di-B–PduA* with CC-Di-A–Citrine, indicated by 
Citrine fluorescence. (b–e) Correlative light electron microscopy of a strain 
expressing CC-Di-B–PduA* and CC-Di-A–GFP, encompassing TEM (b),  
GFP fluorescence (c), overlay (d), and detail of the overlaid image (e).  
(f–h) Fluorescence of cells expressing CC-Di-B–PduA*, CC-Di-A–Citrine, 
and CC-Di-A–mCherry, including Citrine signal (f), mCherry signal (g), and 
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Figure 3 | Ethanol production in vivo. Graph showing ethanol content of 
the growth medium over time normalized to an OD600 = 1. Open circles, 
E. coli strain transformed with empty plasmids (pET14b and pLysS); 
closed circles, strain producing CC-Di-B–PduA* only; open triangles, 
strain producing CC-Di-A–Pdc and CC-Di-A–Adh; closed triangles, strain 
producing CC-Di-A–Pdc, CC-Di-A–Adh and CC-Di-B–PduA*. Data points 
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As a final demonstration of the modularity, versatility and poten-
tial utility of the new cytoscaffold, we tested whether it could be 
directed to the cytoplasmic side of the inner membrane of E. coli 
(Fig. 4). For this, we added the C-terminal membrane-localizing 
region of MinD from Bacillus subtilis to the CC-Di-A–Citrine fusion 
to render CC-Di-A–Citrine–MinD37. When this construct was 
expressed in cells and imaged by confocal fluorescence microscopy, 
halos around the cytoplasm were evident, indicating localization of 
Citrine to the cell membrane (Fig. 4b). This was also the case for 
the C–Citrine–MinD control (Supplementary Fig. 13). When each 
of these were co-expressed with CC-Di-B–PduA* filaments, we 
observed differences in location between control and membrane-
targeting constructs (Fig. 4a and Supplementary Fig. 14).
First, in cells expressing CC-Di-B–PduA* alone, an average 
of 30% of the filaments were associated with the membrane. For 
CC-Di-B–PduA* plus the C–Citrine–MinD control, this localiza-
tion was very similar (31%). In contrast, for the CC-Di-B–PduA* 
plus CC-Di-A–Citrine–MinD combination, 60% of the filaments 
were localized to the inner membrane, and this difference was 
statistically significant (P < 0.01). One-way analysis of variance 
(ANOVA) showed no significant difference (P < 0.01) in the total 
number of filaments between the three strains. Collectively, these 
analyses demonstrated that the cellular spatial location of the 
CC-Di-B–PduA* filaments can be controlled by interactions with 
the cognate de novo–designed coiled-coil peptide.
DISCUSSION
Previously, we and others have shown that individual shell proteins, 
which form the hexameric tiles of the BMC casing, generate long, 
filamentous macromolecular structures when overproduced in host 
bacterial cells30,38. These structures are particularly apparent with 
PduA* from the Pdu BMC. The filaments formed by PduA* are 
approximately 20 nm in diameter; they can be several microns long 
and have a tendency to stack together and align along the length 
of the cell, to the extent that they interfere with cell septation. We 
hypothesized that the PduA* filaments can be formed from the self-
association of the hexameric tiles into a protein sheet that then rolls 
into a nanotubule filament. We wondered whether it would be pos-
sible to target specific proteins to these filaments to generate higher-
order supramolecular organization in the cell by design.
To achieve this, we have employed a heterodimeric coiled-coil 
system, CC-Di-A and CC-Di-B31, previously characterized and 
used, for example, in the de novo construction of peptide cages33. 
We find that whereas fusion of the CC-Di-A sequence onto PduA* 
resulted in low protein production and loss of filament formation, 
attachment of CC-Di-B to PduA* leads to the formation of much 
shorter filaments that are dispersed throughout the cytoplasm. The 
reason for the shorter filaments is not clear, but could be because 
of a slight frustration of hexamer packing when the positively 
charged CC-Di-B peptide is appended or from faster nucleation of 
CC-Di-B–PduA* fusions, resulting in a greater number of shorter 
filaments. Importantly, given the quantity of filaments that are pro-
duced throughout the cell, their formation and presence does not 
appear to alter cell viability or growth.
By adding the complementary CC-Di-A peptide onto fluo-
rescent proteins, we show through imaging techniques that these 
tagged proteins can be recruited to the CC-Di-B–PduA* filaments, 
demonstrating that the filaments can act as a molecular scaffold. A 
key biotechnological use of scaffolds within a cell would be localiza-
tion of biosynthetic enzymes in close proximity to one another to 
facilitate metabolic channeling. This is part of the theory behind 
multienzyme complexes, although in these cases, direct transfer or 
channeling of metabolites from one enzyme to the next also takes 
place. Using simple systems it has been shown that compartmen-
talization of pyruvate decarboxylase and alcohol dehydrogenase 
within a recombinant BMC improves production of ethanol from 
pyruvate21. Similarly, the direct fusion of these two enzymes also 
results in improved flux39, indicating in both cases that having the 
second enzyme in close proximity to the first ensures that the unsta-
ble acetaldehyde intermediate is more efficiently converted into the 
alcohol. Therefore, herein we have targeted pyruvate decarboxylase 
and alcohol dehydrogenase to the CC-Di-B-PduA* filaments using 
the coiled-coil modules, producing significantly more ethanol in 
comparison to when the enzymes are expressed without the scaf-
fold. This provides very strong evidence that the cytoscaffold can be 
used to cluster metabolic enzymes to accelerate the channeling of 
intermediates from one enzyme to the next.
The CC-Di-B peptide can also be used to control the localization 
of the PduA* filaments within the cell. This has been achieved by 
targeting the CC-Di-A-Citrine protein to the inner membrane by 
fusing on the membrane-targeting region of MinD to the C termi-
nus of the construct. Co-expression of this CC-Di-A–Citrine–MinD 
protein with CC-Di-B–PduA* directed filaments to the inner-
membrane. Such localization strategies can be used to ensure that 
pathway-enriched filaments have ready access to metabolites that 
are taken up via transporters or, conversely, to ensure that products 
are generated near the membrane for export out of the cell.
Furthermore, the fact that the CC-Di-B–PduA* filaments are 
able to interact easily with either cytosolic proteins or membrane-
targeted proteins containing the CC-Di-A peptide suggests that the 
N-terminal region of PduA must be solvent exposed. The two sides 
of the hexameric PduA tiles are distinguished by their concave and 
convex appearance. The N terminus of PduA, to which CC-Di-B 
is fused, is located on the concave side of the protein. The fact that 




































Figure 4 | Targeting the bacterial cytoscaffold to the inner membrane 
of E. coli. (a) Box-and-whisker plots showing the number of filaments 
associated with the inner membrane for three strains expressing variants 
of the CC-Di-A/B–PduA* system. Plot 1 = CC-Di-B-PduA*; plot 2 = CC-Di-
B–PduA* + CC-Di-A–Citrine–MinD; plot 3 = CC-Di-B–PduA* + CC-Di-C–
Citrine–MinD. Boxes show first and third quartiles, solid line shows median, 
dotted lines give the mean and whiskers the minimum and maximum; 
250 cells were analyzed for each of the three strains. **P = 0.01; ns, not 
significant. (b) Confocal image of strain expressing CC-Di-A–Citrine–MinD. 
Scale bar, 5 m. (c) TEM micrograph of strains producing CC-Di-B–PduA* 
plus CC-Di-A–Citrine–MinD. Arrows indicate transverse filaments.  
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protein strongly implies that the filament formed from PduA is gen-
erated with the concave side exposed to the solvent. This agrees with 
the recent structure of a recombinant BMC, in which all the shell 
proteins were found to be oriented with the concave side facing out 
of the structure23.
Overall, this work demonstrates a concept for performing and 
evaluating rational protein design in the cell; specifically, making 
hybrid scaffolds comprising de novo–designed peptides and natural 
proteins that can be engineered on the micron scale within the E. coli 
cytoplasm. Visualization of filaments with and without appended 
ancillary proteins, and of those broadly distributed filaments or 
those localized to the inner membrane, demonstrates the potential 
of the system as a universal scaffold for the attachment, dispersion 
or localization of targeted cargo throughout the cell. We believe that 
these features and properties of the cytoscaffold, coupled with its 
ease of decoration and remodeling within cells, will enable applica-
tions in biotechnology and synthetic biology. More generally, this 
ability to design and engineer proteins in the cell could usher in a 
new era of rational protein design and engineering in vivo.
Received 31 May 2017; accepted 1 November 2017; 
published online 11 December 2017
METHODS
Methods, including statements of data availability and any associ-
ated accession codes and references, are available in the online ver-
sion of the paper.
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ONLINE METHODS
Cloning of coiled-coil fused constructs. DNA encoding CC-Di-A and 
CC-Di-B embedded within a GS linker followed by a hexahistidine tag and a 
thrombin cleavage sequence was synthesized and cloned into the XbaI/NdeI 
sites of pET14b. A control sequence containing only a GS linker, hexahisti-
dine tag and thrombin cleavage sequence was also synthesized and cloned by 
the same strategy. Strains and synthesized DNA sequences with corresponding 
amino acid sequences are shown in Supplementary Tables 1 and 2. Plasmids 
and primers used in this study are outlined in Supplementary Tables 3 and 4.
Expression of coiled-coil constructs. E. coli BL21*(DE3)-competent cells were 
transformed with a plasmid(s) containing the gene(s) of interest and plated 
onto LB agar plates supplemented with appropriate antibiotics (100 mg/L 
ampicillin and/or 34 mg/L chloramphenicol). For TEM analysis, 50 mL of LB 
was inoculated1:100 from an overnight starter culture and grown at 37 °C with 
shaking to an OD600 of ~0.4; protein production was induced by the addition 
of IPTG to a final concentration of 400 M, and cultures were subsequently 
incubated overnight at 19 °C with shaking. For time-course analysis, 500 mL 
of LB was inoculated, grown and induced as described above. At time intervals 
50 mL of media was removed for TEM analysis. For purification of nanotubes, 
250 mL LB was inoculated 1:100 from an overnight starter culture and grown 
at 37 °C to an OD600 ~0.4. Protein production was induced by addition of IPTG 
to a final concentration of 400 M, and cultures were then incubated with 
shaking at 19 °C overnight. For confocal imaging experiments 50 mL of LB was 
inoculated 1:100 from an overnight starter culture and grown with shaking at 
37 °C to an OD600 ~0.4. protein production was induced by addition of IPTG to 
a final concentration of 400 M, and cultures were then incubated with shak-
ing at 19 °C for 4 h.
In vivo ethanol production. For in vivo ethanol production, 100 mL of LB sup-
plemented with 4% glucose and appropriate antibiotics was inoculated from 
overnight starter cultures to a starting OD600 of 0.05; cultures were grown at 
28 °C for 120 h with shaking at 150 rpm. Protein production was induced by 
addition of IPTG to a final concentration of 400 M after 4 h of growth. During 
growth, 1 mL samples were removed at 0, 2, 4, 6, 12, 24, 48, 72, 96 and 120 h 
for GC/MS analysis of the growth medium. Samples (1 mL) were also taken at 
each time point for SDS-PAGE analysis. Additional samples (5 mL) were taken 
after 24 h for TEM analysis.
Western blot analysis. Nitrocellulose membranes following transfer and block-
ing were incubated in primary antibody (rabbit anti-PduA, 1 g/mL27, or mouse 
anti-His (Sigma-Aldrich; catalog #H1029; diluted 1:3,000)), and then followed 
by incubation in a secondary antibody coupled to alkaline phosphatase (goat 
anti-rabbit IgG (H+L) alkaline phosphatase conjugate (Bio-Rad; catalog #170-
6518; diluted 1:3,000) or anti-mouse IgG (H+L), AP conjugate (Promega; cata-
log #S3721; diluted 1:5,000)). Bands were visualized by incubation in substrate 
5-bromo-4-chloro-3-indolyl phosphate/nitro blue tetrazolium (BCIP/NBT).
Transmission electron microscopy (TEM) analysis of cells. Cells grown as 
described previously were harvested by centrifugation at 3,000 × g for 10 min. 
The cell pellet was resuspended in 2 mL 2.5% (w/v) glutaraldehyde in 100 mM 
sodium cacodylate buffer, pH 7.2 (CAB), and fixed for 2 h with gentle rotat-
ing (20 rpm). Cells were pelleted by centrifugation at 6,000 × g for 2 min and 
were washed twice for 10 min with 100 mM CAB. Cells were post-fixed with 
1% (w/v) osmium tetroxide in 100 mM CAB for 2 h and subsequently washed 
twice with ddH2O. Cells were dehydrated by incubation in an ethanol gradient 
of 50% EtOH for 10 min, 70% EtOH overnight, and 90% EtOH for 10 min fol-
lowed by three 10 min washes in 100% dry EtOH. Cells were then washed twice 
with propylene oxide for 15 min. Cell pellets were embedded by resuspension 
in 1 mL of a 1:1 mix of propylene oxide and Agar LV Resin and incubated for 
30 min with rotation. Cell pellets were infiltrated twice in 100% Agar LV resin. 
The cell pellet was resuspended in fresh resin and transferred to a 1 mL Beem 
embedding capsule, centrifuged for 5 min at 3,000 × g to concentrate the cells 
to the tip of the mold and incubated for 20 h at 60 °C to polymerize.
Samples were ultra-thin sectioned on a RMC MT-XL ultra-microtome 
with a diamond knife (diatome 45°). Sections (60–70 nm) were collected 
on uncoated 300 mesh copper grids. Grids were stained by incubation in 
4.5% (w/v) uranyl acetate in 1% (v/v) acetic acid solution for 45 min followed 
by washing in a stream of ddH2O. Grids were then stained with Reynolds 
lead citrate for 7 min, which was followed by washing in a stream of ddH2O. 
Electron microscopy was performed using a JEOL-1230 transmission electron 
microscope equipped with a Gatan multiscan digital camera operated at an 
accelerating voltage of 80 kV
Tomography. Sections (250 nm) were cut from the existing blocks, and 15 nm 
gold fiducials (Aurion, TomoSol solution) were applied to both surfaces of the 
sections. The sections were imaged at 200 kV in a Tecnai 20 TEM (FEI, the 
Netherlands) and double tilt series images acquired between −62° to +69.5° 
(first axis) and −68° to +69.5° (second axis) with 1.5° (above 50°) and 2° 
increments (below 50°). The pixel size on the 4k by 4k FEI Eagle camera was 
0.74 nm. The resulting tomograms were reconstructed and combined using 
IMOD software40,41. The tube-like structures were modeled automatically using 
the AMIRA XTracing Extension of the AMIRA software suite, developed for 
automatic tracing of microtubules34. A cylinder template is correlated with the 
data to find and search for the center lines of tubes. A small cropped area was 
used to refine the fitting parameters as shown in Supplementary Video 2 and 
these were then applied to the full data set. AMIRA software was further used 
for visualizing the data.
Measurements of in vivo nanotubes. Diameter measurements of 100 nano-
tubes from 10 cells were calculated in ImageJ42. Length measurements were 
calculated automatically using the XTracing extension of the AMIRA software 
suite. Cropping box measurements were removed manually from the data set, 
leaving a total of 739 tubes.
Purification of CC-Di-B-PduA*. CC-Di-B-tagged PduA* was overproduced 
as described previously. Cells were harvested by centrifugation at 2,683 × g. A 
1 g wet cell pellet was resuspended in 20 mL Yeast Protein Extraction Reagent 
(Thermo Scientific) supplemented with Protease Inhibitor Cocktail Tablets, 
EDTA-Free (Sigma-Aldrich) and 500 Units Benzonase Nuclease (Merck) and 
incubated for 3 h at room temperature with gentle shaking. CC-Di-B-PduA* 
nanotubes were pelleted from the lysate by centrifugation for 5 min at 11,300 × g, 
and the pellet was resuspended in 2 mL of 20 mM Tris–HCl, pH 8, containing 
20 mM NaCl. The suspension was centrifuged for 5 min at 11,000 × g, and 
the resulting nanotube containing pellet was resuspended in 20 mM Tris–HCl, 
pH 8, and centrifuged again as above. The supernatant was removed and 
adjusted with a solution of 5 M NaCl to give a final concentration of 80 mM. A 
final centrifugation step as above was performed, and the resulting pellet was 
analyzed for the presence of PduA* nanotubes.
Analysis of purified nanotubes. TEM: Following purification, 20 L of CC- 
Di-B-PduA* nanotubes were deposited onto Formvar, carbon-coated 300 mesh 
copper grids and incubated to 5 min. Glutaraldehyde (20 L of 2.5% (v/v)) in 
PBS was then added and incubated for a further 5 min before washing in three 
drops of 2.5% (v/v) glutaraldehyde in PBS followed by three drops of ddH2O. 
Grids were stained with 2% (w/v) aqueous uranyl acetate and subsequently 
dried. Electron microscopy was performed using a JEOL-1230 transmission 
electron microscope equipped with a Gatan multiscan digital camera operated 
at an accelerating voltage of 80 kV.
AFM: Purified CC-Di-B-PduA* nanotubes (20 L) were deposited onto 
freshly cleaved mica surfaces and incubated for 5 min, followed by the addi-
tion of 20 L 2.5% (v/v) glutaraldehyde in PBS. Surfaces were washed three 
times with 1 mL of ddH2O then dried under a gentle stream of N2. Images 
were acquired in air at 20 °C using a Bruker MultiMode 8 Scanning probe 
microscope operating under Peak-Force tapping mode (ScanAsyst, Bruker) 
with a ScanAsyst-air probe (Bruker). Areas (10 m × 10 m) were scanned at a 
resolution of 4,096 × 4,096 pixels. Bow and tilt were removed using NanoScope 
Analysis 1.4 (Bruker).
Confocal imaging. Following growth and induction of protein expression, 
1 mL of cells was harvested by centrifugation at 3,000 × g. The resulting cell 






















































Analysis of enzyme levels. Relative amounts of Pdc and Adh were quantified 
by western blot. Total cell lysate samples, adjusted to cell number were ana-
lyzed by SDS–PAGE and subsequently western blot analysis. Peak areas were 
quantified using the gel analysis tool in ImageJ. Due to the higher molecular 
weight band close to CC-Di-A-Adh, half of this peak was quantified with the 
assumption that the peak was symmetrical. Measurements were repeated for 
each of the cultures.
MinD colocalization. DNA encoding the c-terminal membrane-associating 
region of MinD was synthesized and cloned into the SpeI/BlpI sites of pET_
CC_Di_A_Citrine_No_Stop and pET_C_Citrine_No_Stop. Cells were trans-
formed as described previously and grown in LB media at 37 °C with shaking 
to an OD600 ~ 0.4, protein production was induced by addition of IPTG to a 
final concentration of 400 M. Cultures were then incubated with shaking at 
19 °C for 4 h. Cells were harvested, fixed, embedded and sectioned as described 
previously. A total of 250 cells in the transverse orientation for each strain were 
analyzed for the presence and location of transverse CC-Di-B-PduA* nano-
tubes. Statistical analysis was performed in Minitab Software version 17 using a 
one-way ANOVA (analysis of variance) at the 99% level with post-hoc analysis 
by Tukey’s test.
Life sciences reporting summary. Further information on experimental design 
and reagents is available in the Life Sciences Reporting Summary.
Data availability. All data generated or analyzed during this study are included 
in this published article (and supplementary information files) or are available 
from the corresponding authors on reasonable request.
2% (w/v) formaldehyde in PBS. Cells were then washed three more times in 
PBS. Cells (10 L) were pipetted onto a 1.5 thickness coverslip before being 
inverted onto a drop of ProLong Gold antifade mountant (Life Technologies) 
on a glass slide. Slides were incubated at room temperature in the dark for 24 h 
to cure. Images were acquired on a Leica TCS SP8 system attached to a Leica 
DMi8 inverted microscope (Leica Microsystems). Excitation light (514 nm for 
Citrine or 594 nm for mCherry) was provided by a white-light laser with a repe-
tition rate of 80 MHz. Images were acquired using a 100 × 1.4 NA oil immersion 
objective and fluorescence was detected through bandpasses of 520–570 nm 
(Citrine detection) or 600–650 nm (mCherry detection).
Correlative light electron microscopy. Cells (1 L) were harvested by centrif-
ugation at 3,000 × g for 5 min, and then loaded into a 0.1 mm membrane car-
rier (Leica) and vitrified by high pressure freezing (EMPACT2 + RTS, Leica). 
Frozen membrane carriers were transferred into 1 mL of freeze substitution 
medium (0.2% uranyl acetate, 5% H2O, in acetone) and held at −90 °C for 
5 h in an automated freeze substitution unit (AFS2, Leica) equipped with an 
attachment for automated reagent exchange (Freeze Substitution Processor, 
FSP, Leica). Samples were warmed to −45 °C at a rate of 5 °C/h, and held at 
−45 °C for 2 h before washing in acetone and ethanol for 30 min each. Samples 
were then infiltrated with 25%, 50% and 75% dilutions of Lowicryl HM20 
resin for 3 h each before infiltrating with 100% resin overnight, which was 
followed by three further changes of resin for 2 h each. UV polymerization 
was performed over approximately 48 h; Samples were initially kept at −45 °C 
for 16 h, then warmed to 0 °C at a slope of 5 °C/h, and finally kept at 0 °C for 
approximately 14 h.
Following polymerization, blocks were removed from flow through con-
tainers, and carriers were detached using liquid nitrogen and the specimen 
carrier detaching tool (Leica) heated to 40 °C. Blocks were trimmed and sec-
tioned with a 45° diamond knife using an EM UC6 microtome (Leica). 70- and 
300-nm thick sections were collected on carbon-coated pioloform films on H6 
copper finder grids (Agar Scientific). Grids were air dried, mounted in PBS 
between a glass slide and coverslip and imaged by light microscopy using a 
Leica DMI4000 B inverted epifluorescence microscope fitted with a 63× oil 
immersion lens (NA 1.4). After imaging, the grids were washed in H2O and air 
dried before imaging in TEM. Image registration of light and electron micros-
copy images was performed using the eC-CLEM plugin in ICY43.
40. Kremer, J.R., Mastronarde, D.N. & McIntosh, J.R. Computer visualization of 
three-dimensional image data using IMOD. J. Struct. Biol. 116, 71–76 (1996).
41. Mastronarde, D.N. Dual-axis tomography: an approach with alignment 
methods that preserve resolution. J. Struct. Biol. 120, 343–352 (1997).
42. Schindelin, J. et al. Fiji: an open-source platform for biological-image 
analysis. Nat. Methods 9, 676–682 (2012).
43. Paul-Gilloteaux, P. et al. eC-CLEM: lexible multidimensional registration 
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Bacterial microcompartments, BMCs, are proteinaceous organelles that encase a 
specific metabolic pathway within a semi-permeable protein shell. Short 
encapsulation peptides direct cargo proteins to the lumen of the compartments. 
However, the fusion of such peptides to non-native proteins does not guarantee 
encapsulation and often causes aggregation. Here, we report a different approach 
for targeting recombinant proteins to BMCs that utilizes specific de novo coiled-coil 
protein-protein interactions. Attachment of one coiled-coil module to a component of 
the bacterial microcompartment shell, PduA, allows targeting of a fluorescent protein 
marker fused to a cognate coiled-coil partner. This interaction takes place on the 
outer surface of the BMC. The redesign of PduA to generate a new N-terminus on 
the luminal side of the BMC results in intact compartments to which fluorescent 
proteins can still be targeted via the designed coiled-coil system. This study 
demonstrate that de novo coiled-coil peptide technology can be used to target to the 
luminal or cytoplasmic faces of BMCs, allowing proteins to be displayed on the 
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Although once thought to lack subcellular organization, prokaryotes utilize a number 
of mechanisms to systematically arrange cellular enzymes to both enhance 
metabolic pathways and also to protect cellular components from potentially 
damaging intermediates. Re-engineering heterologous metabolic pathways with a 
higher level of organization has become of increasing interest to synthetic biologists 
looking to maximize yields from engineered pathways1. Such mechanisms include 
protein-based scaffolds, DNA scaffolds, protein aggregation and 
compartmentalization2-6. However, in some eubacteria, nature has evolved small 
protein-based organelles called bacterial microcompartments (BMCs) that contain a 
specific metabolic pathway7. These BMCs, which are found in around 20% of 
bacteria, consist of a protein shell that encases the enzymes involved in particular 
metabolic pathways8-11. A recent computational study has revealed that the primary 
function of BMCs is to enhance luminal intermediate concentrations leading to an 
enhancement in metabolic flux12. In addition, there is convincing evidence that 
BMCs protect cells from the toxicity associated with high aldehyde concentrations13, 
14. 
 
BMCs can be broadly divided into two subclasses, anabolic carboxysomes and 
catabolic metabolosomes7, 15. Carboxysomes encase the enzymes carbonic 
anhydrase and ribulose-1,5-bisphosphate carboxylase/oxygenase (RuBisCO) 
leading to high levels of the substrate CO2 to overcome the poor catalytic activity of 
RuBisCO16, 17. Of the catabolic metabolosomes, the organelle associated with 1,2-
propanediol utilization (Pdu) is , to date, the best characterized18-20. This structure, 
approximately 150 nm in diameter, houses the enzymes required for the metabolism 
of 1,2-propanediol (1,2-PD) via the toxic intermediate propionaldehyde to form 1-
propanol and propionyl-CoA18, 21. The genetic information encoding this metabolic 
module is housed on a 23-gene operon, the so-called pdu operon18. Seven genes 
encode for eight proteins that form the shell of the BMC (PduA, B, B’, J, K, N, U, T), 
which either form hexameric (BMC-H), trimeric (BMC-T) or pentameric (BMC-P) 
disks that assemble to form the shell22-25. Indeed a recent structural study has 
revealed the organization of these proteins in a recombinant BMC structure26.  
 
The biotechnological potential of BMCs was first realized through the expression of 
the entire pdu operon in E. coli resulting in the formation of functional 
metabolosomes27. Further work showed that through the expression of a minimal 
set of BMC shell proteins (PduA, B, B’, J, K, N and U) empty BMCs could be readily 
produced and isolated28. Proteins can be targeted to such empty BMCs by fusion to 
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short targeting sequences, namely, D18 and P18, that are naturally found on the N-
terminus of the proteins PduD and PduP, respectively, which are integral 
components of the Pdu metabolosome29-31. These targeting peptides have been 
used to show the targeting of fluorescent proteins to BMCs, and, more recently, they 
have been utilized to construct an in vivo ethanol bioreactor6. For the latter, the 
enzymes pyruvate decarboxylase and alcohol dehydrogenase have been targeted 
to recombinant BMCs by fusion to the D18 and P18 targeting peptides. The 
resulting strains are able to produce more ethanol than strains producing the 
enzymes cytoplasmically, demonstrating that compartmentalization is beneficial to 
this recombinant pathway. Other work has shown that it is possible to utilize 
targeting peptides from different BMCs to target proteins to 1,2-PD utilization BMCs. 
This promiscuity suggests a relatively basic mechanism of targeting32. Indeed, 
sequence analysis reveals a conserved hydrophobic motif among BMC systems 
and subsequent work by Jakobson et al. shows that it is possible to design targeting 
peptides de novo based on this hydrophobic motif32, 33.  
 
Recent work has shown that fusion of the D18 and P18 targeting peptides to 
proteins of an engineered 1,2-PD synthesis pathway results in poor levels of protein 
encapsulation and variable levels of protein aggregation4. Nonetheless, when co-
produced together these large enzyme aggregates produce significantly more 
product than the untagged cytoplasmic variants. Therefore, such active enzyme 
aggregates may provide an alternative strategy to enhance metabolic flux. However, 
aggregation may be problematic if the full potential of BMCs is to be realized and 
therefore alternative-targeting mechanisms may facilitate the further development of 
BMC technology. Towards this goal researchers have recently used protein-
interaction domains such as PDZ, GBD and SH3 to target fluorescent proteins to 
recombinant BMCs in the host Corynebacterium glutamicum34. 
 
Here, we describe an altogether different strategy for targeting recombinant proteins 
to BMCs.  This utilizes de novo designed coiled coils35, 36. By attaching one half of 
an obligate coiled-coil heterodimer to the N-terminal, cytoplasm-facing region of 
PduA, we demonstrate that it is possible to target it with cargo that has been tagged 
with the cognate coiled-coil partner. To target cargo to the luminal side of the BMC, 
PduA was engineered so that its N terminus was luminal facing. This permutated 
version of PduA still forms BMCs when coproduced with the other shell proteins and 
the use of the heterodimeric coiled-coil peptide system then allows for internalization 




Construction of coiled-coil labeled BMCs.  Previously, it has been shown that 
heterologous proteins can be targeted to BMCs by fusion to short targeting peptides 
such as P18 or D18, however such fusions often result in protein aggregation4, 29, 30. 
The de novo coiled-coil peptides CC-Di-A and CC-Di-B have been designed to 
interact specifically with each other and to avoid self-association35, 36. Using these 
peptides, we have demonstrated recently that filaments composed of a CC-Di-B-
PduA* fusion can be targeted with fusions of CC-Di-A to fluorescent proteins such 
as Citrine and mCherry5. Therefore, we wondered if the CC-Di-A/CC-Di-B (CC-Di-
AB) cognate pairing could also be used to target proteins to intact BMCs. To 
investigate this, we generated a range of coiled-coil-PduA fusions with the aim of 
incorporating the fused PduA protein into BMCs within E. coli. To achieve this the 
coiled-coil peptides were fused to the N terminus of PduA via a glycine/serine-based 
linker (GS Linker) but separated by a hexa-histidine tag and a thrombin cleavage 
site. This led to the construction of synthetic genes encoding for CC-Di-A-PduA and 
CC-Di-B-PduA. The N terminus of wild-type PduA is located on the concave side of 
the hexamer and in assembled BMCs faces the cellular cytoplasm26. Hence, 
targeting to the N terminus of PduA should append cargo proteins to the outer 
surface of the organelle. 
 
In other constructs, the sequence for a fluorescent protein (Citrine) was incorporated 
between the thrombin cleavage site and PduA to allow for the production of 
fluorescently labeled, coiled-coil tagged, BMC shells.  This gave CC-Di-A-Citrine-
PduA and CC-Di-B-Citrine-PduA. A control construct, called C-PduA, containing the 
GS Linker, hexa-histidine tag and thrombin cleavage site, but without a coiled-coil 
sequence, was also made. The separate synthetic genes for these modified PduA 
variants were incorporated into a plasmid containing the remaining genes for the 
other shell proteins (PduB, B’, J, K, N, U) required to form empty BMCs. In this way, 
a total of six plasmids encoding CC-Di-A-pduA-U, CC-Di-B-pduA-U, C-pduA-U, CC-
Di-A-Citrine-pduA-U, CC-Di-B-Citrine-pduA-U and C-Citrine-pduA-U were 
transformed individually into E. coli BL21 * (DE3) cells. The resulting strains were 
grown, induced and analyzed by transmission electron microscopy (TEM) after 
fixation, embedding, thin sectioning and staining. TEM analysis revealed the 
presence of BMC structures within thin sections of cells from all six strains that were 
grown (Supplementary Figure 1).  
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The BMCs from the six strains were purified as outlined in methods and were 
subjected to SDS-PAGE analysis. All the purified BMCs produced banding patterns 
typical of a BMC, where the major bands visualized included PduB, PduB’, PduJ, 
PduK and PduU. From the strains harbouring CC-Di-B-PduA and CC-Di-B-Citrine-
PduA, the modified PduAs were readily discernable (Supplementary Figures 2 and 
3). In contrast, purifications of BMCs isolated from strains producing with a CC-Di-A-
PduA or C-PduA did not contain a band of the expected size for PduA suggesting 
that these variants are not incorporated into the BMC shell or that these fusion 
proteins are not produced by E. coli (Supplementary Figures 4 - 7). 
 
To gain a better understanding of the structural characteristics of the modified 
compartments, the purified BMCs were fixed, embedded, thin sectioned and 
stained. TEM analysis revealed closed compartments in all samples, which had 
dimensions similar to native empty Pdu BMCs (Figure 1 and Supplementary Figure 
8). However, the micrographs showed a number of structures within the purified 
samples, which appeared to be broken BMCs. It is possible that these damaged 
BMCs may have been broken during the purification process, which involves high-
speed centrifugation. Lipids and protein aggregates were also visualized in purified 







Figure 1 TEM analysis of thin-sectioned purified BMCs formed with the following 
modified PduA proteins.  (A) CC-Di-A-PduA-U. (B) CC-Di-B-PduA-U. (C) C-PduA-U. 
(D) CC-Di-A-Citrine-PduA-U. (E) CC-Di-B-Citrine-PduA-U. (F) C-Citrine-PduA-U. 
Scale bars show 0.2 µm. 
 
Next, fluorescently labeled BMC variants were examined by confocal microscopy to 
confirm that the modified PduAs were being incorporated into the shells of the 
BMCs. The strain producing the CC-Di-B-Citrine-PduA-U BMCs contained 
fluorescent puncta, indicating that CC-Di-B-Citrine-PduA was indeed incorporated 
into the BMC (Supplementary Figure 9 (B)). However, strains producing CC-Di-A-
Citrine-PduA-U and C-Citrine-PduA-U did not show any such  puncta, suggesting 
that CC-Di-A-Citrine-PduA and C-Citrine-PduA were not incorporated into BMCs. 
These results are consistent with the SDS-PAGE data, where the PduA variants 
were not observed in the latter (Supplementary Figure 9 (A and C)). 
 
Although PduA is a major component of the Pdu BMC it is not essential for BMC 
formation in S. enterica14. This explains why it is possible to observe BMCs in 
samples even though PduA variants are not incorporated into the structure. To 
confirm this for our recombinant BMC system, we constructed a plasmid containing 
the genes required for BMC formation but lacking PduA; i.e., with PduB, B’, J, K, N 
and U. TEM analysis of the strain expressing PduB-U revealed correctly formed 




Figure 2 TEM analyses of E. coli producing the shell proteins PduB, B’, J, K, N and 
U (PduB-U). (A) In vivo, and (B) from lysed cells. Scale bars show 0.2 µm 
 
Targeting to BMCs via coiled-coil interactions.  As mentioned previously, one 
problem with the natural targeting peptides, D18 and P18, is that, when fused to 
some cargo proteins, they can result in protein aggregation, presumably as a result 
of the amphipathic nature of these peptides4, 6, 31. To investigate if similar protein 
aggregation occurs with the coiled-coil peptides, CC-Di-A and CC-Di-B, the peptides 
were fused separately to the fluorescent protein mCherry. Cells expressing the 
corresponding synthetic genes in E. coli were visualized by confocal microscopy. 
For a control (C-mCherry) and for the CC-Di-A-mCherry fusion, this revealed 
dispersed cytoplasmic fluorescence indicative of a soluble protein (Supplementary 
Figures 10A and C). However, expression of CC-Di-B-mCherry resulted in protein 
aggregation as evidenced by fluorescent puncta in the cells, suggesting that some 
self-association of the CC-Di-B-based fusion (Supplementary Figure 10B) 5. 
 
The CC-Di-B-PduA fusion protein appears to be incorporated into the empty BMC 
when co-produced with PduB, B’, J, K, N and U. As the CC-Di-B is attached to the 
N-terminus of PduA, and as the N-terminus of PduA, in the hexamer, is on the 
concave side of the hexamer, it is likely that within the BMC the CC-Di-B peptide will 
be facing into the cytoplasm of the cell26. To test if the coiled-coil peptides were 
accessible to their cognate partner peptide, plasmids encoding CC-Di-B-Citrine-
tagged BMCs were co-expressed with CC-Di-A-tagged mCherry. Confocal 
microscopy revealed co-localized fluorescent puncta within the bacterial cells, 
indicative of an association between the two-tagged components. By contrast, in a 
control strain producing the same CC-Di-B-Citrine-labeled BMCs and C-mCherry 
the mCherry signal remained cytoplasmic indicating no interaction with the BMC 
(Figure 3). Expression of CC-Di-B-tagged BMCs with CC-Di-B-tagged mCherry also 
resulted in co-localization of the florescence, but in this case the areas of 
colocalisation were large and more indicative of protein aggregation. 
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Figure 3 Citrine, mCherry and composite fluorescence signals for E. coli BL21 * 
(DE3) cells expressing CC-Di-B-Citrine-PduA-U with CC-Di-A-mCherry, CC-Di-B-
mCherry or C-mCherry. Scale bars show 5 µm. 
 
Redesign of PduA with a lumen-facing N terminus.  
 
The BMC shell protein PduU contains the same characteristic BMC domain as 
PduA, however, it is circularly permuted; i.e., the protein secondary structure 
elements are identical but are arranged in a different order, which results in the N 
and C termini being located on opposing faces of the hexamer37, 38. However, the 
low occupancy of PduU in recombinant BMC shells precludes its effective use in 
incorporating recombinant proteins into the BMC lumen via coiled-coil interactions21. 
Therefore, we aimed to circularly permute the abundant BMC shell protein PduA to 
make it analogous to PduU; i.e., to relocate the N and C termini to the convex side 
of the hexameric disk whilst retaining the characteristic BMC domain architecture39.  
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This redesign of PduA involved moving part of the C terminus to the N terminus. 
Based on the X-ray crystal structure of PduA40, Val-68 was chosen as the site for 
the permutation: it is exposed on the surface of the hexamer, and we hypothesized 
that permutation of the segment after it should have minimal effect on the structure 
of the hexamer. To achieve this, the C-terminal region of PduA 
(GEVKAVHVIPRPHTDVEKILP) was grafted onto the N terminus, with a flexible 
linker (GSAGSGASG) used to connect the wildtype N and C termini, Figure 4.  
 
 
Figure 4 Circular permutation the shell protein PduA. (A+B) Architecture of the 
PduA hexamer (3NGK). (C) Computationally generated model of our novel 
permuted PduA (PduAP) generated with Phyre241 (magenta) overlaid with the native 
structure (cyan) with the flexible linker joining the native N and C termini highlighted 
in blue. (D) Methodology for creating a circularly permuted PduA with the 
transplanted region highlighted in red and the linker region in cyan. 
 
Synthetic DNA encoding the circularly permuted PduA (PduAP) was inserted into a 
plasmid that allowed for its expression in combination with other shell proteins 
required to form an empty BMC shell (PduB, B’, J, K, N, U) giving the construct 
pLysS-PduAP-U. This was transformed into BL21* (DE3) competent cells and 
expressed by induction with IPTG. After overnight growth the cells were harvested, 
fixed, dehydrated, embedded, thin sectioned and subsequently analyzed by TEM. 
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TEM revealed the presence of BMCs in vivo that were structurally similar to empty 
BMCs made from wildtype proteins (PduA-U), showing that the permutation does 
not have a noticeable effect on the structure (Figure 5A&B). In addition, BMCs 
observed free in the resin, presumably as a result of some cell lysis, were 
morphologically similar to their wildtype PduA-containing counterparts (Figure 
5C&D), providing further evidence that the circular permutation does not affect the 
structure of BMCs. However, attempts to purify BMCs containing PduAP, using the 
previously well-established extraction procedures, failed. Presumably, this is 
because incorporation of PduAP into BMCs changes their solubility characteristics. 
To demonstrate that PduAP was incorporated into the BMCs in vivo, a fluorescent 
version of PduAP was constructed incorporating the CC-Di-B-Citrine module onto its 
N terminus. Confocal microscopy of the strain producing this CC-Di-B-Citrine-
PduAP-U revealed florescent puncta, consistent with this fusion being successfully 
incorporated into the BMC shell (Supplementary Figure 11 (B)). In contrast, strains 
expressing CC-Di-A-Citrine-PduAP-U or C-Citrine-PduAP-U did not have a punctate 
fluorescent phenotype suggesting that these variants are not incorporated into the 
shell of the BMC as seen with the non-permuted variants (Supplementary Figure 11 
(A and C)). 
 
Figure 5 Comparison of wild type PduA BMCs and circularly permuted PduAP 




Targeting to BMCs containing PduAP.  To investigate targeting to PduAP, we 
utilized the same CC-Di-AB system used with PduA35, 36.  Addition of CC-Di-B to 
PduAP, and in the presence of PduB-U, did not disrupt BMC formation 
(Supplementary Figure 12). However, we noted that some malformed BMCs were 
present in these strains, but only to a similar level as observed for the unmodified 
empty shell construct (PduA-U) (Supplementary Figure 8 and 12). BMCs that 
appeared to have been released through cell lysis offered better visualization of the 
structures, and these were morphologically similar to the unmodified control (PduA-
U) and to permuted BMCs lacking the coiled-coil sequence (Figures 5 and 6).  
 
 
Figure 6 TEM analysis of permuted PduA BMCs tagged with coiled-peptides. (A) 
CC-Di-A-PduAP-U. (B) CC-Di-B-PduAP-U. (C) C-PduAP-U. (D) CC-Di-A-Citrine-




Next, we sought to target cargo protein to the coiled-coil tagged PduAP within the 
BMC. Strains were transformed with a plasmid encoding CC-Di-B-Citrine-PduAP-U 
and a second plasmid producing the fluorescent protein reporter (mCherry) tagged 
with either CC-Di-A, CC-Di-B or lacking a coiled-coil sequence (C-mCherry). Strains 
were grown and analyzed by confocal fluorescence microscopy (Figure 7). Co-
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localized fluorescence signals were apparent in the strain expressing CC-Di-B-
Citrine-PduAP-U and CC-Di-A-mCherry, although it must be noted that a high 
amount of cytoplasmic CC-Di-A-mCherry was also present, suggesting that not all of 
the protein is targeted to the BMC (lumen). A wholly cytoplasmic mCherry signal 
was observed in the strain producing CC-Di-B-Citrine-PduAP-U together with 
untagged mCherry (C-mCherry) (Figure 7). Together, these results provide strong 
evidence that it is possible to utilize de novo designed coiled-coil peptides to target 
to the luminal side of BMCs.  
 
 
Figure 7 Citrine, mCherry and composite fluorescence signals from E. coli BL21 * 
(DE3) cells expressing CC-Di-B-Citrine-PduAP-U in conjunction with CC-Di-A-









Previously, we have shown that a de novo designed and highly specific coiled-coil 
peptide pair, termed CC-Di-A and CC-Di-B, can be used to target proteins to 
filamentous tubules formed in the cytoplasm of E. coli.  These tubules, which we 
collectively call a cytoscaffold, are formed by the overproduction of a soluble form of 
the natural bacterial microcompartment (BMC) protein PduA, termed PduA*5. With 
this system, we find that CC-Di-B-PduA* filaments find protein cargoes tagged with 
CC-Di-A, and the results are consistent with the N terminus of PduA* facing the 
cellular cytoplasm. 
 
Therefore, and as detailed herein, we wondered if the same coiled-coil system could 
be used to direct cargo to an empty recombinant BMC within E. coli.  Such BMCs 
are formed from the coordinated production of multiple shell proteins, PduA-U. To 
achieve our goal, we investigated the effect of adding CC-Di-A or CC-Di-B to the N 
terminus of wildtype PduA, and co-producing these variants with the remaining shell 
proteins. We find that only the CC-Di-B-PduA variant incorporates into the 
recombinant BMCs. It appears that CC-Di-A makes the PduA unstable, which is 
also what we observe for tagged versions of PduA*5. 
 
By coproducing CC-Di-B-PduA with PduB-U, intact BMCs are observed by TEM. 
Similar BMCs are also observed for a CC-Di-B-Citrine-PduA version produced with 
PduB-U. In this case, the presence of BMCs is confirmed by confocal microscopy, 
which reveals fluorescent puncta within the cellular cytoplasm. The ability of the CC-
Di-A peptide to bind to the CC-Di-B-PduA variants is demonstrated in vivo with a 
CC-Di-A-mCherry fusion protein: co-production of this with the BMC containing the 
CC-Di-B-Citrine-PduA gives co-localized colored puncta within cells. In these cases, 
on the basis of the X-ray crystal structure of PduA and its likely incorporation into 
the BMC, we suggest that the mCherry is being directed to the outer, cytoplasm-
facing sides of the BMCs. 
 
Therefore, and following on from this, we speculated the coiled-coil peptides could 
be used to target to the luminal side of the BMC through the redesign of PduA to 
relocate the N terminus to the convex side of the hexamer. To achieve this, we 
permutated PduA after residue 68 to maintain its overall structure but to move the N 
and C termini to the opposite side of the molecule. This permutated form of PduA, 
PduAP, forms recombinant BMCs in vivo when co-produced with PduB-U, although 
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these could not be recovered for detailed in vitro analysis, suggesting that the 
PduAP changes the physical properties of the BMC in some way. 
 
Nonetheless, both CC-Di-B and CC-Di-B-Citrine can be fused to PduAP to render 
competent recombinant BMCs. Indeed, the co-production of CC-Di-B-Citrine-PduAP 
with PduB-U gives fluorescent puncta within the cells, consistent with the 
incorporation of PduAP into the BMC. Again, targeting to the CC-Di-B-PduAP-
containing BMCs is demonstrated with a CC-Di-A-mCherry fusion and the co-
localisation of citrine and mCherry signals.  This is consistent with the aim that cargo 
protein is being incorporated within the lumens of the BMCs.  
 
In summary, we have developed methods for the localization of proteins to both the 
outside and the inside of BMCs. Targeting to the outside could be used for display 
of proteins on a comparatively large protein framework, for example, in the 
generation of antibodies. The internal accommodation of proteins can be used to 
engineer new metabolic pathways within the BMC; and such endowed BMC could 
be used as delivery vehicles. Through these approaches we have shown that the 
field of cellular and metabolic engineering depends not only on the implementation 
of natural architectures but also on de novo design redesign, in order to achieve 





















Cloning of constructs 
 
DNA was synthesized by Eurofins Genomics, as described in Supplementary 
Information. Plasmids were constructed as outlined in Supplementary Table 2 with 
primers listed in Supplementary Table 3. 
 
Growth of strains producing BMCs 
 
BL21* (DE3) competent cells were transformed with appropriate plasmids. 50 ml of 
LB supplemented with ampicillin (100 mg/L) and chloramphenicol (34 mg/L) in 
baffled flasks was inoculated from an overnight starter culture. Cells were grown at 
37 °C with shaking to an OD600 ~ 0.4, protein production was induced by addition of 
IPTG to a final concentration of 400 µM. Cultures were then incubated for 2 hours at 





Cells were harvested by centrifugation at 2683 x g, a one gram wet cell pellet was 
resuspended in 20 ml YPER supplemented with Protease Inhibitor Cocktail Tablets, 
EDTA-Free and 500 Units benzonase nuclease and incubated for 3 hours at room 
temperature with gentle shaking. 
 
Purification of CC-Di-A tagged and untagged BMCs  
 
BMCs were pelleted from the lysate by centrifugation for 5 minutes at 11,300 X g, 
the pellet was resuspended in 2 ml 20 mM Tris-HCl pH 8, 20 mM NaCl. The 
suspension was centrifuged at 4 °C for 5 minutes at 11,000 X g. The supernatant, 
containing microcompartments was collected, the NaCl concentration was increased 
to 80 mM. The suspension was centrifuged at 4 °C for 5 minutes at 11,000 X g, the 






Purification of CC-Di-B tagged BMCs 
 
BMCs were pelleted from the lysate by centrifugation for 5 minutes at 11,300 X g, 
the pellet was resuspended in 2 ml 20 mM Tris-HCl pH 8, 20 mM NaCl. The 
suspension was centrifuged at 4 °C for 5 minutes at 11,000 X g. The resulting BMC 
containing pellet was resuspended in 2 ml 20 mM Tris-HCl pH 8 and centrifuged for 
5 minutes at 11,000 X g, the supernatant was collected, the NaCl concentration was 
increased to 80 mM. The suspension was centrifuged as above. The resulting pellet 
was resuspended in an appropriate volume of 20 mM Tris-HCl pH 8 for analysis. 
 
Embedding of samples for TEM analysis 
 
Following growth and induction of protein expression cells were harvested by 
centrifugation at 3000 x g. For embedding of BMCs the final pellet from the 
purification was used in place of a cell pellet. The cell/BMC pellet was resuspended 
in 2 ml 2.5% glutaraldehyde in 100 mM sodium cacodylate buffer pH 7.2 (CAB) and 
fixed for 2 hours with gentle rotating (20 rpm). Cells were pelleted by centrifugation 
at 6000 x g for 2 minutes and were washed twice for 10 minutes with 100 mM CAB. 
Cells were post-fixed with 1% osmium tetroxide in 100 mM CAB for 2 hours and 
subsequently washed twice with ddH2O. Cells were dehydrated by incubation in an 
ethanol gradient, 50% EtOH for 10 minutes, 70% EtOH overnight, 90% EtOH for 10 
minutes followed by three 10 minute washes in 100% dry EtOH. Cells were then 
washed twice with propylene oxide for 15 minutes. Cell pellets were embedded by 
resuspension in 1 ml of a 1:1 mix of propylene oxide and Agar LV Resin and 
incubated for 30 minutes with rotation. Cell pellets were infiltrated twice in 100% 
Agar LV resin. The cell pellet was re-suspended in fresh resin and transferred to a 
1ml Beem embedding capsule, centrifuged for 5 minutes at 3000 x g to concentrate 
the cells to the tip of the mould and incubated for 20 hours at 60 °C to polymerize.  
 
Sectioning and visualization of samples  
 
Samples were ultra-thin sectioned on a RMC MT-XL ultra-microtome with a 
diamond knife (diatome 45°) sections (60 – 70 nm) were collected on un-coated 300 
mesh copper grids. Grids were stained by incubation in 4.5% uranyl acetate in 1% 
acetic acid solution for 45 minutes followed by washing in a stream of ddH2O. Grids 
were then stained with Reynolds lead citrate for 7 minutes followed by washing in a 
stream of ddH2O 
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Electron microscopy was performed using a JEOL-1230 transmission electron 
microscope equipped with a Gatan multiscan digital camera operated at an 
accelerating voltage of 80 kV 
 
Confocal imaging  
 
Following growth and induction of protein expression 1 ml of cells was harvested by 
centrifugation at 3000 x g. The resulting cell pellet was washed 3 times in PBS 
before incubation for 15 minutes in 2% (w/v) formaldehyde in PBS, cells were then 
washed a further 3 times in PBS. Cells (10 μl) were pipetted onto a 1.5 thickness 
coverslip before being inverted onto a drop of ProLong Gold antifade mountant (Life 
Technologies) on a glass slide slides were incubated at room temperature in the 
dark for 24 hours to cure. 
 
Images were acquired on a Zeiss LSM 880 with Airyscan system. Excitation light 
(514 nm for Citrine or 561 nm for mCherry) was provided by an argon lamp (514 
nm) or HeNe Laser (561). Images were acquired using a 100x 1.46 NA oil 
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Supplementary Table 1 Strains used in this study 
Strain Genotype Source 
JM109 endA1, recA1, gyrA96, thi, hsdR17 (rk–, 
mk+), relA1, supE44, Δ(lac-proAB), [F′, 
traD36, proAB, laqIqZΔM15] 
Promega 


















Suppementary Table 2 Plasmids Used in this study 
Plasmid name Description Source 
pET3a Overexpression vector, modified 
to include an SpeI site 5’ of 
BamHI 
Novagen 
pET14b Overexpression vector 
containing N-terminal 
hexahistidine-tag, modified to 
include an SpeI site 5’ of BamHI 
Novagen 
pLysS Basal expression suppressor  Novagen 
pLysS_2 Basal expression suppressor 
containing the T7 promoter-




pLysS_PduABJKNU pLysS-2 containing genes 




pLysS_TBAD_mCherry_PduABJKNU   
pET_CC_Di_A Synthesised Di-A gene fragment 
cloned into XbaI/NdeI sites of 
pET14b 
This study 
pET_CC_Di_B Synthesised Di-B gene fragment 
cloned into XbaI/NdeI sites of 
pET14b 
This study 
pET_ C Synthesised Di-C gene fragment 
cloned into XbaI/NdeI sites of 
pET14b 
This study 
pET3a_PduAB pET3a overexpression vector 
containing the genes PduA and 
PduB 
 
pET_CC_Di_A_PduAB NdeI/SpeI fragment of 
pET3a_PduAB cloned into 
NdeI/SpeI sites of pET_Di_A 
This study 
pET_CC_Di_B_PduAB NdeI/SpeI fragment of 
pET3a_PduAB cloned into 
NdeI/SpeI sites of pET_Di_B 
This study 
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pET_ C_PduAB NdeI/SpeI fragment of 
pET3a_PduAB cloned into 
NdeI/SpeI sites of pET_Di_C 
This study 
pLysS_CC_Di_A_PduABJKNU BglII/AscI fragment of 
pET_Di_A_PduAB cloned into 




pLysS_CC_Di_B_PduABJKNU BglII/AscI fragment of 
pET_Di_B_PduAB cloned into 




pLysS_C_PduABJKNU BglII/AscI fragment of 
pET_Di_C_PduAB cloned into 




pET_CC_Di_A_Citrine_NoStop Citrine PCR product digested 
with AseI/SpeI and ligated into 
NdeI/SpeI sites of  pET_Di_A 
This study 
pET_CC_Di_B_Citrine_NoStop Citrine PCR product digested 
with AseI/SpeI and ligated into 
NdeI/SpeI sites of  pET_Di_B 
This study 
pET_C_Citrine_NoStop Citrine PCR product digested 
with AseI/SpeI and ligated into 
NdeI/SpeI sites of  pET_Di_C 
This study 
pET_CC_Di_A_Citrine_PduAB NdeI/SpeI fragment of 
pET3a_PduAB cloned into 
NdeI/SpeI sites of 
pET_Di_A_Citrine_NoStop 
This study 
pET_CC_Di_B_Citrine_PduAB NdeI/SpeI fragment of 
pET3a_PduAB cloned into 
NdeI/SpeI sites of 
pET_Di_B_Citrine_NoStop 
This study 
pET_C_Citrine_PduAB NdeI/SpeI fragment of This study 
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pET3a_PduAB cloned into 
NdeI/SpeI sites of 
pET_Di_C_Citrine_NoStop 
pLysS_CC_Di_A_Citrine_PduABJKNU BglII/AscI fragment of 
pET_Di_A_Citrine_PduAB 




pLysS_CC_Di_B_Citrine_PduABJKNU BglII/AscI fragment of 
pET_Di_B_Citrine_PduAB 




pLysS_C_Citrine_PduABJKNU BglII/AscI fragment of 
pET_Di_C_Citrine_PduAB 




pET_CC_Di_A_mCherry mCherry PCR product ligated 
into NdeI/SpeI sites of 
pET_Di_A 
This study 
pET_CC_Di_B_mCherry mCherry PCR product ligated 
into NdeI/SpeI sites of 
pET_Di_B 
This study 
pET_C_mCherry mCherry PCR product ligated 
into NdeI/SpeI sites of 
pET_Di_C 
This study 
pET-PduB SpeI/BamHI fragment of 
pET_Perm_PduA_GSA_PduB 
ligated into XbaI/BamHI sites of 
pET_CC_Di_A_PduAB 
This study 
pLysS_PduBJKNU BglII/AscI fragment of pET-PduB 




pET_Perm_PduA_GSA_PduB Synthesised Perm-PduA-GSA- This study 
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PduB gene fragment cloned into 
NdeI/BamHI sites of pET3a 
pLysS_Perm_PduA_GSA_PduBJKNU BglII/AscI fragment of pET_ 
Perm_PduA_GSA_PduB cloned 




pET_CC_Di_A_Perm_PduA_GSA_PduB NdeI/BamHI fragment of 
pET_Perm_PduA_GSA_PduB 
ligated into NdeI/BamHI sites of 
pET_CC_Di_A_PduAB 
This study 
pET_CC_Di_B_Perm_PduA_GSA_PduB NdeI/BamHI fragment of 
pET_Perm_PduA_GSA_PduB 
ligated into NdeI/BamHI sites of 
pET_CC_Di_A_PduAB 
This study 
pET_C_Perm_PduA_GSA_PduB NdeI/BamHI fragment of 
pET_CC_Di_A_PduAB ligated 





NdeI/BamHI fragment of 
pET_Perm_PduA_GSA_PduB 





NdeI/BamHI fragment of 
pET_Perm_PduA_GSA_PduB 
ligated into NdeI/BamHI sites of 
pET_CC_Di_B_Citrine_PduAB 
This study 
pET_C_Citrine_Perm_PduA_GSA_PduB NdeI/BamHI fragment of 
pET_Perm_PduA_GSA_PduB 





BglII/AscI fragment of 
pET_CC_Di_A_Perm_PduA_GS








BglII/AscI fragment of 
pET_CC_Di_B_Perm_PduA_GS





pLysS_C_Perm_PduA_GSA_PduBJKNU BglII/AscI fragment of 
pET_C_Perm_PduA_GSA_Pdu






BglII/AscI fragment of 
pET_CC_Di_A_Citrine_Perm_P
duA_GSA_PduB cloned into 






BglII/AscI fragment of 
pET_CC_Di_B_Citrine_Perm_P
duA_GSA_PduB cloned into 






BglII/AscI fragment of 
pET_C_Citrine_Perm_PduA_GS












Supplementary Table 3:  Oligonucleotides used in this study, restriction sites are 
underlined 
Name Sequence 5’ – 3’ 



































Supplementary Figures  
 
 
Supplementary Figure 1 TEM analysis of E. coli BL21 * (DE3) cells expressing: (A) 
CC-Di-A-PduA-U (B) CC-Di-B-PduA-U (C) C-PduA-U (D) CC-Di-A-Citrine-PduA-U 









Supplementary Figure 2 SDS-PAGE analysis of CC-Di-B labeled BMC purification 
in comparison to a molecular weight marker (M). Lane 1 – lysate, lane 2 – 
supernatant after centrifugation at 11,300 x g, lane 3 – pellet after centrifugation 
(resuspended in 20 mM Tris – HCl pH 8, 20 mM NaCl), lane 4 – pellet after 
centrifugation at 11,000 x g (resuspended in 20 mM Tris – HCl pH 8, 20 mM NaCl), 
lane 5 – supernatant after centrifugation, lane 6 - supernatant after centrifugation of 
resuspended pellet, lane 7 – pellet after centrifugation of resuspended pellet, lane 8 
- supernatant after centrifugation, lane 9 pellet after centrifugation in 80 mM NaCl, 
resuspended in 20 mM Tris-HCl pH 8. 2 μl of sample was loaded in lanes 1 and 2, 








Supplementary Figure 3 SDS-PAGE analysis of CC-Di-B-Citrine labeled BMC 
purification in comparison to a molecular weight marker (M). Lane 1 – lysate, lane 2 
– supernatant after centrifugation at 11,300 x g, lane 3 – pellet after centrifugation 
(resuspended in 20 mM Tris – HCl pH 8, 20 mM NaCl), lane 4 – pellet after 
centrifugation at 11,000 x g (resuspended in 20 mM Tris – HCl pH 8, 20 mM NaCl), 
lane 5 – supernatant after centrifugation, lane 6 - supernatant after centrifugation of 
resuspended pellet, lane 7 – pellet after centrifugation of resuspended pellet, lane 8 
- supernatant after centrifugation, lane 9 pellet after centrifugation in 80 mM NaCl, 
resuspended in 20 mM Tris-HCl pH 8. 2 μl of sample was loaded in lanes 1 and 2, 




Supplementary Figure 4 SDS-PAGE analysis of CC-Di-A labeled BMC purification 
in comparison to a molecular weight marker (M). Lane 1 – lysate, lane 2 – 
supernatant after centrifugation at 11,300 x g, lane 3 – pellet after centrifugation 
(resuspended in 20 mM Tris – HCl pH 8, 20 mM NaCl), lane 4 – pellet after 
centrifugation at 11,000 x g (resuspended in 20 mM Tris – HCl pH 8, 20 mM NaCl), 
lane 5 – supernatant after centrifugation, lane 6 - supernatant after centrifugation in 
80 mM NaCl, lane 7 – pellet after centrifugation in 80 mM NaCl, resuspended in 20 
mM Tris-HCl pH 8. 2 μl of sample was loaded in lanes 1 and 2, lanes 3 to 7 were 




Supplementary Figure 5 SDS-PAGE analysis of C labeled BMC purification in 
comparison to a molecular weight marker (M). Lane 1 – lysate, lane 2 – supernatant 
after centrifugation at 11,300 x g, lane 3 – pellet after centrifugation (resuspended in 
20 mM Tris – HCl pH 8, 20 mM NaCl), lane 4 – pellet after centrifugation at 11,000 x 
g (resuspended in 20 mM Tris – HCl pH 8, 20 mM NaCl), lane 5 – supernatant after 
centrifugation, lane 6 - supernatant after centrifugation in 80 mM NaCl, lane 7 – 
pellet after centrifugation in 80 mM NaCl, resuspended in 20 mM Tris-HCl pH 8. 2 μl 





Supplementary Figure 6 SDS-PAGE analysis of CC-Di-A-Citrine labeled BMC 
purification in comparison to a molecular weight marker (M). Lane 1 – lysate, lane 2 
– supernatant after centrifugation at 11,300 x g, lane 3 – pellet after centrifugation 
(resuspended in 20 mM Tris – HCl pH 8, 20 mM NaCl), lane 4 – pellet after 
centrifugation at 11,000 x g (resuspended in 20 mM Tris – HCl pH 8, 20 mM NaCl), 
lane 5 – supernatant after centrifugation, lane 6 - supernatant after centrifugation in 
80 mM NaCl, lane 7 – pellet after centrifugation in 80 mM NaCl, resuspended in 20 
mM Tris-HCl pH 8. 2 μl of sample was loaded in lanes 1 and 2, lanes 3 to 7 were 




Supplementary Figure 7 SDS-PAGE analysis of C-Citrine labeled BMC purification 
in comparison to a molecular weight marker (M). Lane 1 – lysate, lane 2 – 
supernatant after centrifugation at 11,300 x g, lane 3 – pellet after centrifugation 
(resuspended in 20 mM Tris – HCl pH 8, 20 mM NaCl), lane 4 – pellet after 
centrifugation at 11,000 x g (resuspended in 20 mM Tris – HCl pH 8, 20 mM NaCl), 
lane 5 – supernatant after centrifugation, lane 6 - supernatant after centrifugation in 
80 mM NaCl, lane 7 – pellet after centrifugation in 80 mM NaCl, resuspended in 20 
mM Tris-HCl pH 8. 2 μl of sample was loaded in lanes 1 and 2, lanes 3 to 7 were 









Supplementary Figure 8 TEM micrographs of in-vivo (A) and purified (B) empty 























Supplementary Figure 9 Confocal analysis of E. coli BL21 * (DE3) cells expressing 
(A) CC-Di-A-Citrine-PduA-U (B) CC-Di-B-Citrine-PduA-U (C) C-Citrine-PduA-U. 























Supplementary Figure 10 Confocal analysis of E. coli BL21 * (DE3) cells 
expressing (A) CC-Di-A-mCherry (B) CC-Di-B-mCherry (C) C-mCherry. Scale bars 




























Supplementary Figure 11 Confocal analysis of E. coli BL21 * (DE3) cells 
expressing (A) CC-Di-A-Citrine-PduAP-U (B) CC-Di-B-Citrine-PduAP-U (C) C-


















Supplementary Figure 12 T TEM analysis of E. coli BL21 * (DE3) cells expressing 
permuted PduA variants: (A) CC-Di-A-PduAP-U (B) CC-Di-B-PduAP-U (C) C-PduAP-
U D) CC-Di-A-Citrine-PduAP-U (E) CC-Di-B-Citrine-PduAP-U (F) C-Citrine-PduAP-U. 
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